10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☑	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________

Commission file number: 001-37763

TURNING POINT BRANDS, INC.

(Exact name of registrant as specified in its charter)

Delaware	20-0709285
(State or other jurisdiction of Incorporation or organization)	(I.R.S. Employer Identification No.)
5201 Interchange Way,<br> Louisville, KY	40229
---	---
(Address of principal executive offices)	(Zip Code)

(502) 778-4421

(Registrant’s telephone number, including area code)

Former name, former address and former fiscal year, if changed since last report: not applicable

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.01 par value	TPB	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☑
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

At April 26, 2024, there were 17,621,706 shares outstanding of the registrant’s voting common stock, par value $0.01 per share.

TURNING POINT BRANDS, INC.

TABLE OF CONTENTS

			Page No.
PART I—FINANCIAL INFORMATION
	ITEM 1	Financial Statements (Unaudited)
		Consolidated Balance Sheets as of March 31, 2024, and December 31,<br> 2023	5
		Consolidated Statements of Income for the three months ended March 31, 2024<br> and 2023	6
		Consolidated Statements of Comprehensive Income for the three months ended<br> March 31, 2024 and 2023	7
		Consolidated Statements of Cash Flows for the three months ended March<br> 31, 2024 and 2023	8
		Consolidated Statements of Changes in Stockholders’ Equity for the<br> three months ended March 31, 2024 and 2023	9
		Notes to Consolidated Financial Statements	10
	ITEM 2	Management’s Discussion and Analysis of Financial Condition and<br> Results of Operations	30
	ITEM 3	Quantitative and Qualitative Disclosures about Market Risk	38
	ITEM 4	Controls and Procedures	39
PART II—OTHER INFORMATION
	ITEM 1	Legal Proceedings	40
	ITEM 1A	Risk Factors	40
	ITEM 2	Unregistered Sales of Equity Securities and Use of Proceeds	40
	ITEM 3	Defaults Upon Senior Securities	40
	ITEM 4	Mine Safety Disclosures	40
	ITEM 5	Other Information	40
	ITEM 6	Exhibits	41
	Signatures		42

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (this “Quarterly Report”), contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as “anticipate,” “believe,” “expect,” “intend,” “plan,” and “will” or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events, and depend on circumstances, that may or may not occur in the future. As a result, actual events may differ materially from those expressed in, or suggested by, the forward-looking statements. Any forward-looking statement made by Turning Point Brands, Inc. (“TPB”), in this Quarterly Report on Form 10-Q speaks only as of the date hereof. New risks and uncertainties come up from time to time, and it is impossible for TPB to predict these events or how they may affect it. TPB has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to:

●	declining sales of tobacco products, and expected continuing decline of sales in the tobacco industry overall;
●	our dependence on a small number of third-party suppliers and producers;
---	---
●	the possibility that we will be unable to identify or contract with new suppliers or producers in the event of a supply or product disruption, as well as<br> other supply chain concerns, including delays in product shipments and increases in freight cost;
---	---
●	the possibility that our licenses to use certain brands or trademarks will be terminated, challenged or restricted;
---	---
●	failure to maintain consumer brand recognition and loyalty of our customers;
---	---
●	our reliance on relationships with several large retailers and national chains for distribution of our products;
---	---
●	intense competition and our ability to compete effectively;
---	---
●	competition from illicit sources and the damage caused by illicit products to our brand equity;
---	---
●	contamination of our tobacco supply or products;
---	---
●	uncertainty and continued evolution of the markets for our products;
---	---
●	complications with the design or implementation of our new enterprise resource planning system could adversely impact our business and operations;
---	---
●	substantial and increasing regulation and changes in U.S. Food and Drug Administration (“FDA”) enforcement priorities;
---	---
●	regulation or marketing denials of our products by the FDA, which has broad regulatory powers;
---	---
●	many of our products contain nicotine, which is considered to be a highly addictive substance;
---	---
●	requirement to maintain compliance with master settlement agreement escrow account;
---	---
●	possible significant increases in federal, state and local municipal tobacco- and nicotine-related taxes;
---	---
●	our products are marketed pursuant to a policy of FDA enforcement priorities which could change, and our products could become subject to increased<br> regulatory burdens by the FDA;
---	---
●	our products are subject to developing and unpredictable regulation, such as court actions that impact obligations;
---	---
●	increase in state and local regulation of our products has been proposed or enacted;
---	---
●	increase in tax of our products could adversely affect our business;
---	---
●	sensitivity of end-customers to increased sales taxes and economic conditions, including as a result of inflation and other declines in purchasing power;
---	---
●	possible increasing international control and regulation;
---	---
●	failure to comply with environmental, health and safety regulations;
---	---
●	imposition of significant tariffs on imports into the U.S.;
---	---
●	the scientific community’s lack of information regarding the long-term health effects of certain substances contained in some of our products;
---	---
●	significant product liability litigation;
---	---
●	our amount of indebtedness;
---	---
●	the terms of our indebtedness, which may restrict our current and future operations;
---	---
●	our ability to establish and maintain effective internal controls over financial reporting;
---	---
●	identification of material weaknesses in our internal control over financial reporting, which, if not remediated appropriately or timely, could result in<br> loss of investor confidence and adversely impact our stock price;
---	---
●	our certificate of incorporation and bylaws, as well as Delaware law and certain regulations, could discourage or prohibit acquisition bids or merger<br> proposals, which may adversely affect the market price of our common stock;
---	---
●	our certificate of incorporation limits the ownership of our common stock by individuals and entities that are Restricted Investors. These restrictions may<br> affect the liquidity of our common stock and may result in Restricted Investors (as defined in our Certificate of Incorporation) being required to sell or redeem their shares at a loss or relinquish their voting, dividend and distribution<br> rights;
---	---
●	future sales of our common stock in the public market could reduce our stock price, and any additional capital raised by us through the sale of equity or<br> convertible securities may dilute your ownership in us;
---	---

●	we may issue preferred stock whose terms could adversely affect the voting power or value of our common stock;
●	our business may be damaged by events outside of our suppliers’ control, such as the impact of epidemics (e.g., coronavirus), political upheavals, or natural<br> disasters;
---	---
●	adverse impact of climate change;
---	---
●	our reliance on information technology;
---	---
●	cybersecurity and privacy breaches, which have increased in part due to artificial intelligence;
---	---
●	failure to manage our growth;
---	---
●	failure to successfully integrate our acquisitions or otherwise be unable to benefit from pursuing acquisitions;
---	---
●	fluctuations in our results;
---	---
●	exchange rate fluctuations;
---	---
●	adverse U.S. and global economic conditions;
---	---
●	departure of key management personnel or our inability to attract and retain talent;
---	---
●	infringement on or misappropriation of our intellectual property;
---	---
●	third-party claims that we infringe on their intellectual property; and
---	---
●	failure to meet expectations relating to environmental, social and governance factors.
---	---

PART I—FINANCIAL INFORMATION

Item 1.

    Financial Statements

Turning Point Brands, Inc.

Consolidated

  Balance Sheets

(dollars in thousands except share data)


			December 31,
ASSETS			2023
Current assets:
Cash	130,903		$	117,886
Accounts receivable, net of allowances of 43 in 2024 and 78 in 2023	8,198			9,989
Inventories, net	105,467			98,960
Other current assets	34,437			40,781
Total current assets	279,005			267,616
Property, plant, and equipment, net	24,790			25,300
Deferred income taxes	1,426			1,468
Right of use assets	10,868			11,480
Deferred financing costs, net	2,305			2,450
Goodwill	136,365			136,250
Other intangible assets, net	80,177			80,942
Master Settlement Agreement (MSA) escrow deposits	28,427			28,684
Other assets	22,953			15,166
Total assets	586,316		$	569,356
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	18,934		$	8,407
Accrued liabilities	30,974			33,635
Current portion of long-term debt	59,397			58,294
Total current liabilities	109,305			100,336
Notes payable and long-term debt	306,496			307,064
Lease liabilities	9,360			9,950
Total liabilities	425,161			417,350
Commitments and contingencies
Stockholders’ equity:
Preferred stock; 0.01 par value; authorized shares 40,000,000; issued and outstanding<br> shares -0-	–			–
Common stock, voting, 0.01 par value; authorized<br> shares, 190,000,000; 20,016,822 issued shares and 17,627,817 outstanding shares at March 31, 2024, and 19,922,137<br> issued shares and 17,605,677 outstanding shares at December 31, 2023	200			199
Common stock, nonvoting, 0.01 par value; authorized shares, 10,000,000; issued and<br> outstanding shares -0-	–			–
Additional paid-in capital	119,792			119,075
Cost of repurchased common stock (2,389,005 shares at March 31, 2024 and 2,316,460 shares December 31, 2023)	(80,172	)		(78,093	)
Accumulated other comprehensive loss	(3,048	)		(2,648	)
Accumulated earnings	123,192			112,443
Non-controlling interest	1,191			1,030
Total stockholders’ equity	161,155			152,006
Total liabilities and stockholders’ equity	586,316		$	569,356

All values are in US Dollars.

The accompanying notes are an integral part of the consolidated financial statements.

Turning Point Brands, Inc.

Consolidated Statements of Income

(dollars in thousands except share and per share data)

(unaudited)

	Three Months Ended<br><br> <br>March 31,
	2024			2023
Net sales	$	97,058		$	100,956
Cost of sales		45,146			52,339
Gross profit		51,912			48,617
Selling, general, and administrative expenses		32,646			30,775
Operating income		19,266			17,842
Interest expense, net		3,479			4,010
Investment (gain) loss		(119	)		4,799
Gain on extinguishment of debt		–			(777	)
Income before income taxes		15,906			9,810
Income tax expense		3,727			2,468
Consolidated net income		12,179			7,342
Net income (loss) attributable to non-controlling interest		169			(255	)
Net income attributable to Turning Point Brands, Inc.	$	12,010		$	7,597
Basic income per common share:
Net income attributable to Turning Point Brands, Inc.	$	0.68		$	0.43
Diluted income per common share:
Net income attributable to Turning Point Brands, Inc.	$	0.63		$	0.41
Weighted average common shares outstanding:
Basic		17,654,684			17,531,414
Diluted		20,170,314			20,669,152

The accompanying notes are an integral part of the consolidated financial statements.

Turning Point Brands, Inc.

Consolidated Statements of Comprehensive Income

(dollars in thousands)

(unaudited)


			2023
Consolidated net income	12,179		$	7,342
Other comprehensive income (loss), net of tax
Unrealized loss on MSA investments, net of tax of 15 in 2024 and 176 in 2023	(242	)		553
Foreign currency translation, net of tax of 0 in 2024 and 2023	13			(78	)
Unrealized loss on derivative instruments, net of tax of 57 in 2024 and 109 in 2023	(185	)		(344	)
Unrealized gain on investments, net of tax of 0 in 2024	6			–
	(408	)		131
Consolidated comprehensive income	11,771			7,473
Comprehensive income (loss) attributable to non-controlling interest	169			(255	)
Comprehensive income attributable to Turning Point Brands, Inc.	11,602		$	7,728

All values are in US Dollars.

The accompanying notes are an integral part of the consolidated financial statements.

Turning Point Brands, Inc.

Consolidated Statements of

  Cash Flows

(dollars in thousands)

(unaudited)

	Three<br> Months Ended<br><br> <br>March 31,
	2024			2023
Cash flows from operating activities:
Consolidated net income	$	12,179		$	7,342
Adjustments to reconcile net income to net cash provided by operating activities:
Gain on extinguishment of debt		–			(777	)
Loss (gain) on sale of property, plant, and equipment		1			(6	)
Gain on MSA investments		6			–
Depreciation and other amortization expense		944			776
Amortization of other intangible assets		779			771
Amortization of deferred financing costs		696			626
Deferred income tax expense (benefit)		114			299
Stock compensation expense		2,062			743
Noncash lease income		(42	)		(14	)
Loss on investments		–			4,897
Changes in operating assets and liabilities:
Accounts receivable		1,929			(216	)
Inventories		(6,296	)		6,173
Other current assets		3,130			2,639
Other assets		(270	)		(2,895	)
Accounts payable		10,525			2,051
Accrued liabilities and other		(3,118	)		(7,025	)
Net cash provided by operating activities	$	22,639		$	15,384
Cash flows from investing activities:
Capital expenditures	$	(366	)	$	(2,435	)
Purchases of investments		(7,119	)		–
Purchases of non-marketable equity investments		(500	)		–
Proceeds on sale of property, plan and equipment		–			3
Restricted cash, MSA escrow deposits		(1	)		–
Net cash used in investing activities	$	(7,986	)	$	(2,432	)
Cash flows from financing activities:
Convertible Senior Notes repurchased	$	–		$	(13,002	)
Proceeds from call options		–			33
Payment of dividends		(1,149	)		(1,052	)
Exercise of options		3			357
Redemption of restricted stock units		(136	)		–
Redemption of performance restricted stock units		(1,212	)		(889	)
Common stock repurchased		(2,079	)		–
Net cash used in financing activities	$	(4,573	)	$	(14,553	)
Net increase (decrease) in cash	$	10,080		$	(1,601	)
Effect of foreign currency translation on cash	$	(58	)	$	(1	)
Cash, beginning of period:
Unrestricted	$	117,886		$	106,403
Restricted		4,929			4,929
Total cash at beginning of period	$	122,815		$	111,332
Cash, end of period:
Unrestricted	$	130,903		$	104,801
Restricted		1,934			4,929
Total cash at end of period	$	132,837		$	109,730
Supplemental schedule of noncash investing activities:
Accrued capital expenditures	$	10		$	7
Supplemental schedule of noncash financing activities:
Dividends declared not paid	$	1,261		$	1,155

The accompanying notes are an integral part of the consolidated financial statements.

Turning Point Brands, Inc.

Consolidated Statements of Changes in Stockholders’ Equity

For the Three Months Ended March 31, 2024 and 2023

(dollars in thousands except share data)

(unaudited)

								Cost of			Accumulated
			Common		Additional			Repurchased			Other						Non-
			Stock,		Paid-In			Common			Comprehensive			Accumulated			Controlling
			Voting		Capital			Stock			Income (Loss)			Earnings			Interest			Total
Beginning balance January 1, 2024	17,605,677		$	199	$	119,075		$	(78,093	)	$	(2,648	)	$	112,443		$	1,030		$	152,006
Unrealized loss on MSA investments, net of tax of 15	–			–		–			–			(242	)		–			–			(242	)
Unrealized loss on derivative instruments, net of tax of 57	–			–		–			–			(185	)		–			–			(185	)
Foreign currency translation, net of tax of 0	–			–		–			–			21			–			(8	)		13
Unrealized gain on investments, net of tax of 0	–			–		–			–			6			–			–			6
Stock compensation expense	–			–		2,062			–			–			–			–			2,062
Exercise of options	198			–		3			–			–			–			–			3
Cost of repurchased common stock	(72,545	)		–		–			(2,079	)		–			–			–			(2,079	)
Issuance of performance based restricted stock units	126,109			1		–			–			–			–			–			1
Issuance of restricted stock units	21,697			–		–			–			–			–			–			–
Redemption of performance based restricted stock units	(48,177	)		–		(1,212	)		–			–			–			–			(1,212	)
Redemption of restricted stock units	(5,142	)		–		(136	)		–			–			–			–			(136	)
Dividends	–			–		–			–			–			(1,261	)		–			(1,261	)
Net income	–			–		–			–			–			12,010			169			12,179
Ending balance March 31, 2024	17,627,817		$	200	$	119,792		$	(80,172	)	$	(3,048	)	$	123,192		$	1,191		$	161,155
Beginning balance January 1, 2023	17,485,163		$	198	$	113,242		$	(78,093	)	$	(2,393	)	$	78,691		$	1,735		$	113,380
Unrealized gain on MSA investments, net of tax of 176	–			–		–			–			553			–			–			553
Unrealized loss on derivative instruments, net of tax of 109	–			–		–			–			(344	)		–			–			(344	)
Foreign currency translation, net of tax of 0	–			–		–			–			(50	)		–			(28	)		(78	)
Stock compensation expense	–			–		743			–			–			–			–			743
Exercise of options	24,955			–		357			–			–			–			–			357
Performance restricted stock units issuance	114,274			1		(1	)		–			–			–			–			–
Performance restricted stock units redeemed	(38,863	)		–		(889	)		–			–			–			–			(889	)
Settlement of call options, net of tax of 8	–			–		25			–			–			-			-			25
Dividends	–			–		–			–			–			(1,155	)		–			(1,155	)
Net income	–			–		–			–			–			7,597			(255	)		7,342
Ending balance March 31, 2023	17,585,529		$	199	$	113,477		$	(78,093	)	$	(2,234	)	$	85,133		$	1,452		$	119,934

All values are in US Dollars.

The accompanying notes are an integral part of the consolidated financial statements.

Turning Point Brands, Inc.

Notes to Consolidated

  Financial Statements

(dollars in thousands, except where designated and per share data)

Note 1. Description of Business and Basis of Presentation

Description of Business

Turning Point Brands, Inc. and its subsidiaries (collectively referred to herein as the “Company,” “we,” “our,” or “us”) is a leading manufacturer, marketer and distributor of branded consumer products. The Company sells a wide range of products to adult consumers consisting of staple products with its iconic brands Zig-Zag^®^and Stoker’s^®^and its next generation products to fulfill evolving consumer preferences. Its segments are led by its core proprietary and iconic brands: Zig-Zag^®^ and CLIPPER^®^ in the Zig-Zag Products segment and Stoker’s^®^ along with Beech-Nut^®^ and Trophy^®^ in the Stoker’s Products segment. The

    Company’s products are available in more than

217

,000 retail outlets in North America. The Company operates in three segments: (i) Zig-Zag Products, (ii) Stoker’s Products, and (iii) Creative Distribution Solutions (formerly known as NewGen).

Basis of Presentation

The accompanying unaudited, interim, consolidated financial statements have been prepared in accordance with the accounting practices described in the Company’s audited, consolidated financial statements as of and for the year ended December 31, 2023. In the opinion of management, the unaudited, interim, consolidated financial statements included herein contain all adjustments necessary to present fairly the financial position, results of operations, and cash flows of the Company for the periods presented. Such adjustments, other than nonrecurring adjustments separately disclosed, are of a normal and recurring nature. The operating results for interim periods are not necessarily indicative of results to be expected for a full year or future interim periods. The unaudited, interim, consolidated financial statements should be read in conjunction with the Company’s audited, consolidated financial statements and accompanying notes as of and for the year ended December 31, 2023. The accompanying interim, consolidated financial statements are presented in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) and, accordingly, do not include all the disclosures required by generally accepted accounting principles in the United States (“GAAP”) with respect to annual financial statements.

Note 2. Summary of Significant Accounting Policies

Consolidation

The consolidated financial statements include the accounts of the Company, its subsidiaries, all of which are wholly-owned, and variable interest entities for which the Company is considered the primary beneficiary. All significant intercompany transactions have been eliminated.

Revenue Recognition

The Company recognizes revenues in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers (Topic 606), which includes excise taxes and shipping and handling charges billed to customers, net of cash discounts for prompt payment, sales returns and incentives, upon delivery of goods to the customer – at which time the Company’s performance obligation is satisfied - at an amount that the Company expects to be entitled to in exchange for those goods in accordance with the five-step analysis outlined in Topic 606: (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations, and (v) recognize revenue when (or as) performance obligations are satisfied. The Company excludes from the transaction price, sales taxes and value-added taxes imposed at the time of sale (which do not include excise taxes on smokeless tobacco, cigars or other nicotine products billed to customers).

The Company records an allowance for sales returns, based principally on historical volume and return rates, which is included in accrued liabilities on the consolidated balance sheets. The Company records sales incentives, which consist of consumer incentives and trade promotion activities, as a reduction in revenues (a portion of which is based on amounts estimated to be due to wholesalers, retailers and consumers at the end of the period) based principally on historical volume and utilization rates. Expected payments for sales incentives are included in accrued liabilities on the consolidated balance sheets.

A further requirement of ASC 606 is for entities to disaggregate revenue recognized from contracts with customers into categories that depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. The Company’s management views business performance through segments that closely resemble the performance of major product lines. Thus, the primary and most useful disaggregation of the Company’s contract revenue for decision making purposes is the disaggregation by segment which can be found in Note 16, “Segment Information”. An additional disaggregation of contract revenue by sales channel can be found within Note 16 as well.

Shipping Costs

The Company records shipping costs incurred as a component of selling, general, and administrative expenses. Shipping costs incurred were approximately $5.6 million and $6.2 million for the three months ending March 31, 2024 and 2023, respectively.

Inventories

Inventories are stated at the lower of cost or net realizable value using the first-in, first-out method. Leaf tobacco is presented in current assets in accordance with standard industry practice, notwithstanding the fact that such tobaccos are carried longer than one year for the purpose of curing.

Fair Value

GAAP establishes a framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3).

The three levels of the fair value hierarchy under GAAP are described below:

●	Level 1 – Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets at the measurement date.
●	Level 2 – Inputs to the valuation methodology include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar<br> assets or liabilities in inactive markets, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
---	---
●	Level 3 – Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement<br> date.
---	---

Derivative Instruments

The Company enters into foreign currency forward contracts to hedge a portion of its exposure to changes in foreign currency exchange rates on inventory purchase commitments. The Company accounts for its forward contracts under the provisions of ASC 815, Derivatives and Hedging. Under the Company’s policy, the Company may hedge up to 100% of its anticipated purchases of inventory in the denominated invoice currency over a forward period not to exceed twelve months. The Company may also, from time to time, hedge up to 100% of its non-inventory purchases (e.g., production equipment) in the denominated invoice currency. Forward contracts that qualify as hedges are adjusted to their fair value through other comprehensive income as determined by market prices on the measurement date, except any hedge ineffectiveness which is recognized currently in income. Gains and losses on these forward contracts are reclassified from other comprehensive income into inventory as the related inventories are received and are transferred to net income as inventory is sold. Changes in fair value of any contracts that do not qualify for hedge accounting or are not designated as hedges are recognized currently in income.

Risks and Uncertainties

Manufacturers and sellers of tobacco products are subject to regulation at the federal, state, and local levels. Such regulations include, among others, labeling requirements, limitations on advertising, and prohibition of sales to minors. The tobacco industry is likely to continue to be heavily regulated. There can be no assurance as to the ultimate content, timing, or effect of any regulation of tobacco products by any federal, state, or local legislative or regulatory body, nor can there be any assurance that any such legislation or regulation would not have a material adverse effect on the Company’s financial position, results of operations, or cash flows. In a number of states targeted flavor bans have been proposed or enacted legislatively or by the administrative process. Depending on the number and location of such bans, that legislation or regulation could have a material adverse effect on the Company’s financial position, results of operations or cash flows. The U.S. Food and Drug Administration (“FDA”) continues to consider various restrictive regulations around our products, including targeted flavor bans; however, the details, timing, and ultimate implementation of such measures remain unclear.

The tobacco industry has experienced, and is experiencing, significant product liability litigation. Most tobacco liability lawsuits have been brought against manufacturers and sellers of cigarettes for injuries allegedly caused by smoking or exposure to smoke. However, several lawsuits have been brought against manufacturers and sellers of smokeless products for injuries to health allegedly caused by use of smokeless products. Typically, such claims assert that use of smokeless products is addictive and causes oral cancer. Additionally, several lawsuits have been brought against manufacturers and distributors of Creative Distribution Solutions products due to malfunctioning devices. There can be no assurance the Company will not sustain losses in connection with such lawsuits and that such losses will not have a material adverse effect on the Company’s financial position, results of operations, or cash flows.

Master Settlement Agreement (MSA)

Pursuant to the Master Settlement Agreement (the “MSA”) entered into in November 1998 by most states (represented by their attorneys general acting through the National Association of Attorneys General) and subsequent states’ statutes, a “cigarette manufacturer” (which is defined to include a manufacturer of make-your-own (“MYO”) cigarette tobacco) has the option of either becoming a signatory to the MSA or opening, funding, and maintaining an escrow account to have funds available for certain potential tobacco-related liabilities with sub-accounts on behalf of each settling state. Such companies are entitled to direct the investment of the escrowed funds and withdraw any appreciation but cannot withdraw the principal for twenty-five years from the year of each annual deposit, except to withdraw funds deposited pursuant to an individual state’s escrow statute to pay a final judgement to that state’s plaintiffs in the event of such a final judgement against the Company. The Company chose to open and fund an escrow account as its method of compliance. It is the Company’s policy to record amounts on deposit in the escrow account for prior years as a non-current asset. As of March 31, 2024, the Company had on deposit approximately $32.1 million, the fair value of which was approximately $28.4 million. At December 31, 2023, the Company had on deposit approximately $32.1 million, the fair value of which was approximately $28.7 million. The Company discontinued its generic category of MYO in 2019 and its Zig-Zag^^branded MYO cigarette smoking tobacco in 2017. Thus, pending a change in MSA legislation, the Company has no remaining product lines covered by the MSA and will not be required to make future escrow deposits.

The Company has chosen to invest a portion of the MSA escrow, from time to time, in U.S. Government securities including TIPS, Treasury Notes, and Treasury Bonds. These investments are classified as available-for-sale and carried at fair value. Realized losses are prohibited under the MSA; any investment in an unrealized loss position will be held until the value is recovered, or until maturity.

Fair values for the U.S. Governmental agency obligations are Level 2 in the fair value hierarchy. The following tables show cost and estimated fair value of the assets held in the MSA account, respectively, as well as the maturities of the U.S. Governmental agency obligations held in such account for the periods indicated.

	As of March 31, 2024							As of December 31, 2023
			Gross			Estimated				Gross			Estimated
			Unrealized			Fair				Unrealized			Fair
	Cost		Gains (Losses)			Value		Cost		Losses			Value
Cash and cash equivalents	$	1,934	$	–		$	1,934	$	1,929	$	–		$	1,929
U.S. Governmental agency obligations (unrealized position < 12 months)		1,196		6			1,202		–		–			–
U.S. Governmental agency obligations (unrealized position > 12 months)		28,943		(3,652	)		25,291		30,144		(3,389	)		26,755
	$	32,073	$	(3,646	)	$	28,427	$	32,073	$	(3,389	)	$	28,684
	As of
---	---	---
	March 31, 2024
Less than one year	$	3,250
One to five years		13,775
Five to ten years		11,159
Greater than ten years		1,955
Total	$	30,139

The following shows the amount of deposits by sales year for the MSA escrow account:

	Deposits as of
Sales<br><br> <br> <br>Year	March 31,<br><br> <br>2024		December 31,<br><br> <br>2023
1999	$	211	$	211
2000		1,017		1,017
2001		1,673		1,673
2002		2,271		2,271
2003		4,249		4,249
2004		3,714		3,714
2005		4,553		4,553
2006		3,847		3,847
2007		4,167		4,167
2008		3,364		3,364
2009		1,619		1,619
2010		406		406
2011		193		193
2012		199		199
2013		173		173
2014		143		143
2015		101		101
2016		91		91
2017		82		82
Total	$	32,073	$	32,073

Note 3. Derivative Instruments

Foreign Currency

During the three months ended March 31, 2024, the Company executed no foreign exchange contracts meeting hedge accounting requirements.

At March 31, 2024, the Company had foreign currency contracts outstanding for the purchase of €9.2 million and sale of €9.2 million. The foreign currency contracts’ fair value at March 31, 2024, resulted in an asset of $0.0 million included in Other current assets and a liability of $0.1 million included in Accrued liabilities. At December 31, 2023, the Company had foreign currency contracts outstanding for the purchase of €15.2 million and sale of €15.2 million. The foreign currency contracts’ fair value at December 31, 2023, resulted in an asset of $0.3 million included in Other current assets and a liability of $0.1 million included in Accrued liabilities.

Note 4. Fair Value of Financial Instruments

The estimated fair value amounts have been determined by the Company using the methods and assumptions described below. However, considerable judgment is required to interpret market data to develop estimates of fair value. Accordingly, the estimates presented herein are not necessarily indicative of the amounts the Company could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts.

Cash and Cash Equivalents

Cash and cash equivalents are, by definition, short-term. Thus, the carrying amount is a reasonable estimate of fair value.

Accounts Receivable

The fair value of accounts receivable approximates their carrying value due to their short-term nature.

Long-Term Debt

The Company’s Senior Secured Notes (as defined in Note 10) bear interest at a rate of 5.625% per year. As of March 31, 2024, the fair value approximated $237.3 million, with a carrying value of $250 million. As of December 31, 2023, the fair value of the Senior Secured Notes approximated $234.9 million, with a carrying value of $250 million.

The Convertible Senior Notes (as defined in Note 10) bear interest at a rate of 2.50% per year, and the fair value of the Convertible Senior Notes without the conversion feature approximated $117.5 million, with a carrying value of $118.5 million as of March 31, 2024. As of December 31, 2023, the fair value of the Convertible Senior Notes without the conversion feature approximated $114.7 million, with a carrying value of $118.5 million.

See Note 10, “Notes Payable and Long-Term Debt”, for further information regarding the Company’s long-term debt.

Note 5. Inventories

The components of inventories are as follows:

	March 31,		December 31,
	2024		2023
Raw materials and work in process	$	7,148	$	5,201
Leaf tobacco		41,461		34,894
Finished goods - Zig-Zag Products		39,103		41,783
Finished goods - Stoker’s Products		10,232		8,090
Finished goods - Creative Distribution Solutions		6,086		7,281
Other		1,437		1,711
Inventories	$	105,467	$	98,960

The inventory valuation allowance was $20.6 million as of March 31, 2024 and December 31, 2023.

In December 2023, a third-party warehouse in Tennessee used to store some of the Company’s leaf tobacco incurred significant tornado damage resulting in damage to the leaf tobacco. As a result, the Company recorded a $15.2 million inventory reserve related to its leaf tobacco inventory which is included in Other operating income, net in the consolidated statement of income for the quarter ended December 31, 2023. The leaf tobacco inventory is covered by the Company’s stock throughput insurance policy and the Company believes the inventory loss is probable of being fully recovered under the policy. The Company does not expect to incur any delays in customer deliveries as a result of the damage.

Note 6. Other Current Assets

Other current assets consist of:

	March 31,		December 31,
	2024		2023
Inventory deposits	$	7,392	$	5,707
Insurance deposit		–		3,000
Prepaid taxes		–		153
Settlement receivable		–		4,000
Insurance recovery receivable		15,181		15,181
Other		11,864		12,740
Total	$	34,437	$	40,781

Note 7. Property, Plant, and Equipment

Property, plant, and equipment consists of:

	March 31,			December 31,
	2024			2023
Land	$	22		$	22
Buildings and improvements		4,217			3,956
Leasehold improvements		6,614			5,440
Machinery and equipment		28,568			29,751
Furniture and fixtures		8,439			8,391
Gross property, plant and equipment		47,860			47,560
Accumulated depreciation		(23,070	)		(22,260	)
Net property, plant and equipment	$	24,790		$	25,300

Note 8. Other Assets

Other assets consist of:

	March 31,		December 31,
	2024		2023
Non-marketable equity investments	$	2,882	$	2,405
Debt security investment		6,750		6,750
Capitalized software		6,108		5,923
Available-for-sale marketable securities		7,125		–
Other		88		88
Total	$	22,953	$	15,166

Debt and Non-Marketable Equity Investments

The Company records its non-marketable equity investments without a readily determinable fair value, that are not accounted for under the equity method, at cost, with adjustments for impairment and observable price changes. Should assumptions underlying the determination of the fair values of the Company’s non-marketable equity and debt security investments change, it could result in material future impairment charges.

In January 2024, the Company invested $0.8 million to acquire an 18.744% stake in Teaza Energy, LLC (“TeaZa”). TeaZa is an innovative brand of flavorful oral pouch products that can be dipped or sipped, designed as a health-conscious alternative to high energy drinks and other conventional oral stimulants. The investment is comprised of $0.5 million in cash and a $0.3 million payable to be offset against the Company’s allocated portion of future profit distributions. The Company also has options to purchase, at fair value, up to 51.744% of the equity interest in TeaZa between September 30, 2024 and January 31, 2025, and up to 100% of the equity interest from February 1, 2025 to June 30, 2026. The Company accounts for its investment in TeaZa using the equity method of accounting.

In July 2021, the Company invested $8.0 million in Old Pal Holding Company LLC (“Old Pal”). In July 2022, the Company invested an additional $1.0 million in Old Pal. The Company invested in the form of a convertible note which includes additional follow-on investment rights. The accrued interest of $0.2 million from July 2021 to July 2022 was rolled into the convertible note in July 2022 resulting in a total investment of $9.2 million. Old Pal is a leading brand in the cannabis lifestyle space that operates a non-plant touching licensing model. The convertible note bears an interest rate of 3.0% per year and matures July 31, 2026.Interest and principal not paid to date are receivable at maturity. Old Pal has the option to extend the maturity date in one-year increments. The interest rate is subject to change based on Old Pal reaching certain sales thresholds. The weighted average interest rate on the convertible note was 3.0% for the three months ended March 31, 2024 and 2023. Old Pal has the option to convert the note into shares once sales reach a certain threshold. The conditions required to allow Old Pal to convert the note were not met as of March 31, 2024. Additionally, the Company has the right to convert the note into shares at any time. The Company has classified the debt security with Old Pal as available for sale. The Company reports interest income on available for sale debt securities in interest income in our Consolidated Statements of Income. Quarterly, we perform a qualitative assessment to determine if the fair value of the investment could be less than the amortized cost basis. In the second and fourth quarters of 2023, based on third-party quantitative assessments of the fair value using a Monte Carlo simulation (Level 3), the Company determined the fair value to be $7.7 million and 6.9 million, respectively, and recorded an allowance for credit losses of $0.3 million and $1.0 million, respectively, included in investment loss for the quarters ended June 30 and December 31, 2023. The Company has recorded accrued interest receivable of $0.2 million and $0.1 million at March 31, 2024 and December 31, 2023, respectively, in Other current assets on our Consolidated Balance Sheets.

            April 2021, the Company invested $8.7 million in Docklight Brands, Inc., a pioneering consumer products company with celebrated
            brands including Marley Natural® and Marley™. The Company has additional follow-on investment rights. As part of the investment, the Company has obtained exclusive U.S. distribution rights for Docklight’s Marley™ CBD topical products. In
            the first quarter of 2023, based on Docklight’s financial results and other operating difficulties, and the decline in the revenue multiples for public companies comparable to Docklight, the Company deemed the investment in Docklight was
            impaired resulting in a loss of $4.9 million which was recorded for the three months ended March 31, 2023. In the second quarter
            of 2023, based on a significant change in Docklight’s business model, the Company deemed its investment in Docklight fully impaired. Fair value for all periods presented was determined using a valuation derived from relevant revenue
            multiples \(Level 3\).

Available-for-Sale Marketable Securities

In December 2023, the Company formed a captive insurance company, Interchange IC, incorporated in the District of Columbia, to write a portion of our general product, and officer and director liability coverages under deductible reinsurance policies. Interchange IC is a fully licensed captive insurance company holding a certificate of authority from the District of Columbia Department of Insurance, Securities and Banking. Interchange IC is a wholly-owned subsidiary of Turning Point Brands and is consolidated in the Company’s financial statements.

The investments held within the captive are not available for operating activities and are carried at fair value on the consolidated balance sheet. They consist of money market, corporate bonds, government securities, real estate investment trusts and exchange traded funds. The Company believes any impairment of investments held with gross unrealized losses to be temporary and not the result of credit risk.

The Company’s captive investments are summarized in the following table.

	As of March 31, 2024
				Gross				Estimated
	Amortized			Unrealized				Fair
	Cost			Gains (Losses)				Value
Corporate bonds		$	1,703		$	8			$	1,711
U.S. Governmental agency obligations			1,799			(3	)			1,796
Real estate investment trusts and exchange traded funds			3,617			1				3,618
		$	7,119		$	6			$	7,125

The following table summarizes the fair value of the Company’s captive investments by contractual maturity.

	As of
	March 31, 2024
Due within one year	$	1,711
Due after ten years		1,796
Real estate investment trusts and exchange traded funds		3,618
Total investments at fair value	$	7,125

Note 9. Accrued Liabilities

Accrued liabilities consist of:

	March 31,		December 31,
	2024		2023
Accrued payroll and related items	$	4,669	$	7,085
Customer returns and allowances		4,642		5,239
Taxes payable		6,995		3,821
Lease liabilities		2,615		2,678
Accrued interest		2,221		6,682
Other		9,832		8,130
Total	$	30,974	$	33,635

Note 10. Notes Payable and Long-Term Debt

Notes payable and long-term debt consists of the following in order of preference:

	March 31,			December 31,
	2024			2023
Senior Secured Notes	$	250,000		$	250,000
Convertible Senior Notes		118,541			118,541
Gross notes payable and long-term debt		368,541			368,541
Less deferred finance charges		(2,648	)		(3,183	)
Less current maturities		(59,397	)		(58,294	)
Notes payable and long-term debt	$	306,496		$	307,064

Senior Secured Notes

On February 11, 2021, the Company closed a private offering (the “Offering”) of $250.0 million aggregate principal amount of its 5.625% senior secured notes due 2026 (the “Senior Secured Notes” or the “Notes”). The Senior Secured Notes bear interest at a rate of 5.625% and will mature on February 15, 2026. Interest on the Senior Secured Notes is payable semi-annually in arrears on February 15 and August 15 of each year, commencing on August 15, 2021.The Company used the proceeds from the Offering (i) to repay all obligations under and terminate the 2018 First Lien Credit Facility, (ii) to pay related fees, costs, and expenses and (iii) for general corporate purposes.

Obligations under the Senior Secured Notes are guaranteed by the Company’s existing and future wholly-owned domestic subsidiaries (the “Guarantors”) that guarantee any credit facility (as defined in the indenture governing the Senior Secured Notes or the “Senior Secured Notes Indenture”) or capital markets debt securities of the Company or Guarantors in excess of $15.0 million. The Senior Secured Notes and the related guarantees are secured by first-priority liens on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions.

The Company may redeem the Senior Secured Notes, in whole or in part, at any time at the redemption prices (expressed as a percentage of the principal amount to be redeemed) set forth below, plus accrued and unpaid interest, if any, on the Senior Secured Notes to be redeemed to (but not including) the applicable redemption date if redeemed during the period indicated below:

On or after February 15, 2023	102.813	%
On or after February 15, 2024	101.406	%
On or after February 15, 2025 and thereafter	100.000	%

If the Company experiences a change of control (as defined in the Senior Secured Notes Indenture), the Company must offer to repurchase the Senior Secured Notes at a repurchase price equal to 101% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest.

The Senior Secured Notes Indenture contains covenants that, among other things, restrict the ability of the Company and its restricted subsidiaries to: (i) grant or incur liens; (ii) incur, assume or guarantee additional indebtedness; (iii) sell or otherwise dispose of assets, including capital stock of subsidiaries; (iv) make certain investments; (v) pay dividends, make distributions or redeem or repurchase capital stock; (vi) engage in certain transactions with affiliates; and (vii) consolidate or merge with or into, or sell substantially all of our assets to another entity. These covenants are subject to a number of limitations and exceptions set forth in the Senior Secured Notes Indenture. The Senior Secured Notes Indenture provides for customary events of default. The Company was in compliance with all covenants as of March 31, 2024.

The Company incurred debt issuance costs attributable to the issuance of the Senior Secured Notes of $6.4 million which are amortized to interest expense using the straight-line method over the expected life of the Senior Secured Notes.

2021 Revolving Credit Facility

In connection with the Offering, the Company also entered into a $25.0 million senior secured revolving credit facility (the “2021 Revolving Credit Facility”) with the lenders party thereto and Barclays Bank PLC, as administrative agent and collateral agent (in such capacity, the “Agent”). On May 10, 2023, the Company and certain of its subsidiaries, as guarantors, entered into an amendment (the “Amendment”) to the 2021 Revolving Credit Facility (as amended, the “Amended Revolving Credit Facility”). The Amendment includes certain modifications to the 2021 Revolving Credit Facility relating to the replacement of the London Inter-Bank Offered Rate with a Secured Overnight Financing Rate (“SOFR”) as the interest rate benchmark under the 2021 Revolving Credit Facility and adjusts certain other provisions to reflect current documentation standards and other agreed modifications.

On November 7, 2023, in connection with the entry by a subsidiary of the Company in a new asset-backed revolving credit facility, the Company terminated the Amended Revolving Credit Facility. See “2023 ABL Facility” below.

The Company had letters of credit outstanding under the Amended Revolving Credit Facility of approximately $1.4 million that were terminated with the facility in the fourth quarter of 2023.

The Company incurred debt issuance costs attributable to the issuance of the Amended Revolving Credit Facility of $0.5 million, with the remaining $0.2 million written off to gain on debt extinguishment upon termination of the facility.

2023 ABL Facility

On November 7, 2023, TPB Specialty Finance, LLC, a wholly-owned subsidiary of the Company (the “ABL Borrower”), entered into a new $75.0 million asset-backed revolving credit facility (the “2023 ABL Facility”), with the several lenders thereunder, and Barclays Bank Plc, as administrative agent (the “Administrative Agent”) and as collateral agent (the “Collateral Agent”) and First-Citizens Bank & Trust Company as additional collateral agent (the “Additional Collateral Agent”). Under the 2023 ABL Facility, the ABL Borrower may draw up to $75.0 million under Revolving Credit Loans and Last In Last Out (“LILO”) Loans. The 2023 ABL Facility includes a $40.0 million accordion feature. In connection with the 2023 ABL Facility, Turning Point Brands contributed certain existing inventory to the ABL Borrower. The 2023 ABL Facility is secured on a first priority basis (subject to customary exceptions) by all assets of the ABL Borrower.

The 2023 ABL Facility contains customary borrowing conditions including a borrowing base equal to the sum of (a) the lesser of (1) 85% of the lower of (A) the market value (on a first in first out basis) of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (B) 85% of the cost of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (2) 85% of the net orderly liquidation value (“NOLV”) percentage of the lower of (1)(A) or (1)(B); plus (b) 85% of the face value of all eligible accounts of the ABL Borrower minus (c) the amount of all eligible reserves. The 2023 ABL Facility also includes a LILO borrowing base equal to the sum of (a) the lesser of: (1) 10% of the lower of (A) the market value (on a first in first out basis) of the sum of eligible inventory, plus eligible in-transit inventory of the ABL Borrower and (B) the cost of the sum of eligible inventory, plus eligible in-transit inventory and (2) 10% of the NOLV percentage of the lower of (1)(A) or (1)(B); plus (b) 10% of the face amount of eligible account; minus (c) the amount of all eligible reserves.

Amounts borrowed under the 2023 ABL Facility are subject to an interest rate margin

      per annum equal to \(a\) from and after the closing date until the last day of the first full fiscal quarter ended after the closing date, \(i\) 1.25% per annum, in the case base rate loans, and \(ii\) 2.25%
      per annum, in the case of revolving credit loans that are SOFR Loans, \(b\)\(i\) 2.25% per annum, in the case of LILO loans that are base
      rate loans, and \(ii\) 3.25% per annum, in the case of LILO loans that are SOFR loans, \(c\) on the first day of each fiscal quarter, the
      applicable interest rate margins will be determined from the pricing grid below based upon the historical excess availability for the most recent fiscal quarter ended immediately prior to the relevant date, as calculated by the Administrative
      Agent.

Level	Historical Excess Availability	Applicable Margin<br><br> <br>for SOFR Loans	Applicable Margin<br><br> <br>for Base Rate Loans
I	Greater than or equal to 66.66%	1.75%	0.75%
II	Less than 66.66%, but greater than or equal to 33.33%	2.00%	1.00%
III	Less than 33.33%	2.25%	1.25%

The 2023 ABL Facility also requires the Company and its restricted subsidiaries to maintain a fixed charge coverage ratio of at least 1.00 to 1.00 as of the end of any four consecutive fiscal quarters if excess availability shall be less than the greater of (a) 12.5% of the line cap and (b) $9.4 million, at any time and continuing until excess availability is equal to or exceeds the greater of (i) 12.5% of the line and (ii) $9.4 million for thirty (30) consecutive calendar days; provided that such $9.4 million level shall automatically increase in proportion to the amount of any increase in the aggregate revolving credit commitments thereunder in connection with any incremental facility.

The 2023 ABL Facility shall mature on the earlier of (x) November 7, 2027 and (y) the date that is 91 days prior to the maturity date of any material debt of the ABL Borrower or the Company or any of its restricted subsidiaries (subject to customary extensions agreed by the lenders thereunder); provided that clause (y) shall not apply to the extent that on any applicable date of determination (on any date prior to the date set forth in clause (y)), (A) the sum of (x) cash that is held in escrow for the repayment of such material debt pursuant to arrangements satisfactory to the Administrative Agent, (y) cash that is held in accounts with the Administrative Agent and/or the Additional Collateral Agent, plus (z) excess availability, is sufficient to repay such material debt and (B) the ABL Borrower has excess availability of at least $15.0 million after giving effect to such repayment of material debt, including any borrowings under the commitments in connection therewith.

The Company has not drawn any borrowings under the 2023 ABL Facility but has letters of credit of approximately $1.2 million outstanding under the facility and has an available balance of $59.0 million based on the borrowing base as of March 31, 2024.

The Company incurred debt issuance costs attributable to the 2023 ABL Facility of $2.6 million which are amortized to interest expense using the straight-line method over the expected life of the 2023 ABL Facility.

Convertible Senior Notes

In July 2019, the Company closed an offering of $172.5 million in aggregate principal amount of its 2.50% Convertible Senior Notes due July 15, 2024 (the “Convertible Senior Notes”). The Convertible Senior Notes bear interest at a rate of 2.50% per year, payable semiannually in arrears on January 15 and July 15 of each year, beginning on January 15, 2020. The Convertible Senior Notes are senior unsecured obligations of the Company.

In 2023, a wholly owned subsidiary of the Company repurchased $44.0 million in aggregate principal amount of the Convertible Senior Notes on the open market resulting in a $1.9 million gain on extinguishment of debt. The repurchased notes continue to be held by our subsidiary and may be resold subject to compliance with applicable securities law. As of March 31, 2024, $118.5 million aggregate principal remains outstanding and held by third parties.

The Convertible Senior Notes held by third parties are convertible into approximately 2,219,704 shares of TPB Common Stock under certain circumstances prior to maturity at a conversion rate of 18.7252 shares per $1,000 principal amount of the Convertible Senior Notes, which represents a conversion price of approximately $53.40 per share, subject to adjustment under certain conditions, but will not be adjusted for any accrued and unpaid interest. The conversion price is adjusted periodically as a result of dividends paid by the Company in excess of pre-determined thresholds of $0.04 per share. Upon conversion, the Company may pay cash, shares of common stock or a combination of cash and stock, as determined by the Company at its discretion. The conditions required to allow the holders to convert their Convertible Senior Notes were not met as of March 31, 2024.

As discussed above, on November 7, 2023, a wholly-owned subsidiary of the Company entered into the 2023 ABL Facility to refinance up to $75.0 million of the Convertible Senior notes at maturity. As a result, the Company classified $59.0 million related to the Convertible Senior Notes in Notes payable and long-term debt on the Company’s March 31, 2024 Consolidated Balance Sheet. Based on current liquidity, free cash flow generation and availability under the 2023 ABL Facility, the Company believes it will have sufficient liquidity to address the maturity of the remaining Convertible Senior Notes.

The Company incurred debt issuance costs attributable to the Convertible Senior Notes of $5.9 million which are amortized to interest expense using the straight-line method over the expected life of the Convertible Senior Notes.

In connection with the Convertible Senior Notes offering, the Company entered into privately negotiated capped call transactions with certain financial institutions. The capped call transactions have a strike price of $53.40 per share and a cap price of $82.86 per share, and are exercisable when, and if, the Convertible Senior Notes are converted. The Company paid $20.53 million for these capped calls at the time they were entered into and charged that amount to additional paid-in capital.

Note 11. Leases

The Company’s leases consist primarily of leased property for manufacturing, warehouse, corporate offices and retail space, as well as vehicle leases. At lease inception, the Company recognizes a lease right of use asset and lease liability calculated as the present value of future minimum lease payments. In general, the Company does not recognize any renewal periods within the lease terms as there are no significant barriers to ending the lease at the initial term. Lease and non-lease components are accounted for as a single lease component.

Leases with an initial term of 12 months or less are not recorded on the balance sheet. Lease expense for these leases is recognized on a straight-line basis over the lease term.

The components of lease expense consisted of the following:

	Three Months Ended March 31,
	2024		2023
Operating lease cost
Cost of sales	$	133	$	128
Selling, general and administrative		464		521
Variable lease cost (1)		297		225
Short-term lease cost		–		6
Total	$	894	$	880
(1)	Variable lease cost includes elements of a contract that do<br> not represent a good or service but for which the lessee is responsible for paying.
---	---
	Three Months Ended March 31,
---	---	---	---	---
	2024		2023
Financing lease cost
Selling, general and administrative	$	150	$	338
Total	$	150	$	338
	March 31,		December 31,
---	---	---	---	---
	2024		2023
Assets:
Right of use assets - Operating	$	8,714	$	8,950
Right of use assets - Financing		2,154		2,530
Total lease assets	$	10,868	$	11,480
Liabilities:
Current lease liabilities - Operating<br> (2)	$	1,946	$	1,991
Current lease liabilities - Financing (2)		669		687
Long-term lease liabilities - Operating		7,925		8,374
Long-term lease liabilities - Financing		1,435		1,576
Total lease liabilities	$	11,975	$	12,628
(2)	Reported within accrued liabilities on the balance sheet.
---	---

Note 12. Income Taxes

The Company’s effective income tax rate for the three months ended March 31, 2024 was 23.4%. The Company’s effective income tax rate for the three months ended March 31, 2023 was 25.2%.

The Company follows the provisions of ASC 740-10-25, which prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. The Company has determined that the Company did not have any uncertain tax positions requiring recognition under the provisions of ASC 740-10-25. The Company’s policy is to recognize interest and penalties accrued on uncertain tax positions, if any, as part of interest expense. The Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. In general, the Company is no longer subject to U.S. federal and state tax examinations for years prior to 2020.

Note 13. Share Incentive Plans

On March 22, 2021, the Company’s Board of Directors adopted the Turning Point Brands, Inc. 2021 Equity Incentive Plan (the “2021 Plan”), pursuant to which awards may be granted to employees, non-employee directors, and consultants. In addition, the 2021 Plan provides for the granting of nonqualified stock options to employees of the Company or any subsidiary of the Company. Pursuant to the 2021 Plan, 1,290,000 shares, plus 100,052 shares remaining available for issuance under the 2015 Equity Incentive Plan (the “2015 Plan”), of TPB Common Stock are reserved for issuance as awards to employees, non-employee directors, and consultants as compensation for past or future services or the attainment of certain performance goals. The 2021 Plan is scheduled to terminate on March 21, 2031. The 2021 Plan is administered by the compensation committee (the “Committee”) of the Company’s Board of Directors. The Committee determines the vesting criteria for the awards, with such criteria to be specified in the award agreement. As of March 31, 2024, net of forfeitures, there were 400,682 Restricted Stock Units (“RSUs”), 161,658 options and 102,216 Performance Based Restricted Stock Units (“PRSUs”) granted under the 2021 Plan. There are 725,496 shares available for future grant under the 2021 Plan.

On April 28, 2016, the Board of Directors of the Company adopted the 2015 Plan, pursuant to which awards could have been granted to employees, non-employee directors, and consultants. In addition, the 2015 Plan provided for the granting of nonqualified stock options to employees of the Company or any subsidiary of the Company. Upon adoption of the 2021 Plan, the 2015 Plan was terminated, and the Company determined no additional grants would be made under the 2015 Plan. However, all awards issued under the 2015 Plan that have not been previously terminated or forfeited remain outstanding and continue unaffected. There are no shares available for grant under the 2015 Plan.

On February 8, 2006, the Board of Directors of the Company adopted the 2006 Equity Incentive Plan (the “2006 Plan”) of North Atlantic Holding Company, Inc., pursuant to which nonqualified stock options and restricted stock awards may be granted to employees. Upon the adoption of the Company’s 2015 Equity Incentive Plan in connection with its IPO, the Company determined no additional grants would be made under the 2006 Plan. However, all awards issued under the 2006 Plan that have not been previously terminated or forfeited remain outstanding and continue unaffected. There are no shares available for grant under the 2006 Plan.

Stock option activity for the 2006, 2015 and 2021 Plans is summarized below:

				Weighted		Weighted
	Stock			Average		Average
	Option			Exercise		Grant Date
	Shares			Price		Fair Value
Outstanding, December 31, 2022		683,214		$	29.74	$	9.24
Granted		77,519			20.71		6.45
Exercised		(33,851	)		13.30		4.24
Forfeited		(69,931	)		27.51		9.11
Outstanding, December 31, 2023		656,951		$	29.79	$	9.18
Granted		54,289			27.19		9.21
Exercised		(198	)		14.85		4.41
Forfeited		(6,433	)		30.19		8.85
Outstanding, March 31, 2024		704,609		$	29.59	$	9.19

Under the 2006, 2015 and 2021 Plans, the total intrinsic value of options exercised during the three months ended March 31, 2024 and 2023, was $0.0 million, and $0.2 million, respectively.

At March 31, 2024, under the 2006 Plan, the exercise price for the 43,693 outstanding options is $3.83 per share, all of which are exercisable. The weighted average of the remaining lives of the outstanding stock options with an exercise price of $3.83 is approximately 0.35 years. The Company estimates the expected life of these stock options is ten years from the date of grant. For the $3.83 per share options, the weighted average fair value of options at the date of grant was determined using the Black-Scholes model with the following assumptions: a ten-year life from grant date, a current share price and exercise price of $3.83, a risk-free interest rate of 3.57%, volatility of 40%, and no assumed dividend yield. Based on these assumptions, the fair value of these options is approximately $2.17 per share option granted.

At March 31, 2024, under the 2015 and 2021 Plans, the risk-free interest rate is based on the U.S. Treasury rate for the expected life at the time of grant. The expected volatility is based on the average long-term historical volatilities of peer companies. We intend to continue to consistently use the same group of publicly traded peer companies to determine expected volatility until sufficient information regarding volatility of our share price becomes available or until the selected companies are no longer suitable for this purpose. Due to our limited trading history, we are using the simplified method presented by SEC Staff Accounting Bulletin No. 107 to calculate expected holding periods, which represent the periods of time for which options granted are expected to be outstanding. We will continue to use this method until we have sufficient historical exercise experience to give us confidence in the reliability of our calculations. The fair values of these options were determined using the Black-Scholes option pricing model.

The following table outlines the assumptions based on the number of options granted under the 2015 Plan.

	February 10,			May 17,			March 7,			March 20,			October 24,			March 18,			February 18,			May 3,
	2017			2017			2018			2019			2019			2020			2021			2021
Number of options granted		40,000			93,819			98,100			155,780			25,000			155,000			100,000			12,000
Options outstanding at March 31, 2024		20,000			38,033			51,067			124,864			25,000			77,777			87,350			12,000
Number exercisable at March 31, 2024		20,000			38,033			51,067			124,864			25,000			77,777			87,350			12,000
Exercise price	$	13.00		$	15.41		$	21.21		$	47.58		$	20.89		$	14.85		$	51.75		$	47.76
Remaining lives		2.87			3.13			3.94			4.97			5.57			5.97			6.89			7.09
Risk free interest rate		1.89	%		1.76	%		2.65	%		2.34	%		1.58	%		0.79	%		0.56	%		0.84	%
Expected volatility		27.44	%		26.92	%		28.76	%		30.95	%		31.93	%		35.72	%		28.69	%		29.03	%
Expected life		6.000			6.000			6.000			6.000			6.000			6.000			6.000			6.000
Dividend yield		–			–			0.83	%		0.42	%		0.95	%		1.49	%		0.55	%		0.59	%
Fair value at grant date	$	3.98		$	4.60		$	6.37		$	15.63		$	6.27		$	4.41		$	13.77		$	13.06

The following table outlines the assumptions based on the number of options granted under the 2021 Plan.

	May 17,			March 14,			April 29,			May 12,			March 11,
	2021			2022			2022			2023			2024
Number of options granted		7,500			100,000			14,827			77,519			54,289
Options outstanding at March 31, 2024		7,500			70,690			14,827			77,519			54,289
Number exercisable at March 31, 2024		7,500			47,442			9,935			77,519			–
Exercise price	$	45.05		$	30.46		$	31.39		$	20.71		$	27.19
Remaining lives		7.13			7.96			8.08			9.12			9.95
Risk free interest rate		0.84	%		2.10	%		2.92	%		3.41	%		4.06	%
Expected volatility		31.50	%		35.33	%		35.33	%		34.51	%		35.09	%
Expected life		6.000			6.000			6.000			5.186			5.186
Dividend yield		0.63	%		1.01	%		0.98	%		1.61	%		1.26	%
Fair value at grant date	$	13.23		$	10.23		$	11.07		$	6.45		$	9.21

The Company has recorded compensation expense related to the options based on the provisions of ASC 718 under which the fixed portion of such expense is determined as the fair value of the options on the date of grant and amortized over the vesting period. The Company recorded compensation expense related to the options of approximately $0.3 million and $0.0

    million for the three months ended March 31, 2024 and 2023, respectively. Total unrecognized compensation expense related to options at March 31, 2024, is $0.3
    million, which will be expensed over 0.75 years.

PRSUs are restricted stock units subject to both performance-based and service-based vesting conditions. The number of shares of TPB Common Stock a recipient will receive upon vesting of a PRSU will be calculated by reference to certain performance metrics related to the Company’s performance over a five-year period. PRSUs will vest on the measurement date, which is no more than 65 days after the performance period provided the applicable service and performance conditions are satisfied. As of March 31, 2024, there are 447,266 PRSUs outstanding. The

      following table outlines the PRSUs granted and outstanding as of March

31, 2024

	March 18,		February 18,		March 14,		May 4,		March 1,
	2020		2021		2022		2023		2024
Number of PRSUs granted		94,000		100,000		49,996		133,578		111,321
PRSUs outstanding at March 31, 2024		80,910		82,190		40,325		132,520		111,321
Fair value as of grant date	$	14.85	$	51.75	$	30.46	$	22.25	$	26.52
Remaining lives		0.75		1.75		2.75		1.75		2.75

The Company recorded compensation expense related to the PRSUs of approximately $0.9 million and $0.5 million in the consolidated statements of income for the three months ended March 31, 2024 and 2023, respectively, based on the probability of achieving the performance condition. Total unrecognized compensation expense related to these awards at March 31, 2024, is $6.1 million which will be expensed over the service periods based on the probability of achieving the performance condition.

The Company has granted 325,523 RSUs which are outstanding and vest over one to five years. The following table outlines the RSUs granted and outstanding as of March 31, 2024.

	March 14,		March 14,		April 29,		May 5,		May 8,		March 1,		March 11,
	2022		2022		2022		2023		2023		2024		2024
Number of RSUs granted		50,004		28,726		4,522		130,873		20,101		105,257		18,389
RSUs outstanding at March 31, 2024		39,367		9,481		4,522		128,406		20,101		105,257		18,389
Fair value as of grant date	$	30.46	$	30.46	$	31.39	$	22.25	$	21.77	$	26.52	$	27.19
Remaining lives		2.75		0.75		2.75		2.00		0.10		3.00		0.75

The Company has recorded compensation expense related to the RSUs based on the provisions of ASC 718 under which the fixed portion of such expense is determined as the fair value of the RSUs on the date of grant and amortized over the vesting period. The Company recorded compensation expense related to the RSUs of approximately $0.9 million and $0.3 million for the three months ended March 31, 2024 and 2023. Total unrecognized compensation expense related to RSUs at March 31, 2024, is $5.1 million, which will be expensed over 2.52 years.

Note 14. Contingencies

On October 9, 2020, a purported stockholder of Turning Point Brands, Inc., Paul-Emile Berteau, filed a complaint in the Delaware Court of Chancery relating to the merger of Standard Diversified, Inc. (“SDI”) with a TPB subsidiary (“Merger Sub”)pursuant to the Agreement and Plan of Merger and Reorganization, dated as of April 7, 2020, by and among TPB, SDI and Merger Sub. The parties attended a mediation in late November 2022 where a settlement was reached. On December 12, 2023, the Court approved the settlement and dismissed the action with prejudice. As of December 31, 2023, the Company recorded a $4.0 million receivable in other current assets, and a corresponding gain on settlement in other income on its Consolidated Statement of Income for the year ended December 31, 2023. These funds were received in January 2024.

Other major tobacco companies are defendants in product liability claims. In a number of these cases, the amounts of punitive and compensatory damages sought are significant and, if such a claim were brought against the Company, could have a material adverse effect on our business and results of operations. The Company is subject to several lawsuits alleging personal injuries resulting from malfunctioning vaporizer devices or batteries and may be subject to claims in the future relating to our other Creative Distribution Solutions products. The Company is still evaluating these claims and the potential defenses to them. For example, the Company did not design or manufacture the products at issue; rather, the Company was merely the distributor. Nonetheless, there can be no assurance that the Company will prevail in these cases, and they could have a material adverse effect on the financial position, results of operations or cash flows of the Company.

We have several subsidiaries engaged in making, distributing, and selling liquid nicotine products. As a result of the overall publicity and controversy surrounding the industry generally, many companies have received informational subpoenas from various regulatory bodies and in some jurisdictions regulatory lawsuits have been filed regarding marketing practices and possible underage sales. We expect that our subsidiaries will be subject to some

  such cases and investigative requests. To the extent that litigation becomes necessary, we believe that the subsidiaries have strong factual and legal defenses against claims that they unfairly marketed products.

Note 15. Income Per Share

The following is a reconciliation of the numerators and denominators of the basic and diluted EPS computations of net income:

	Three Months Ended March 31,
	2024						2023
					Per						Per
	Income		Shares		Share		Income		Shares		Share
Basic EPS:
Numerator
Net income attributable to Turning Point Brands, Inc.	$	12,010					$	7,597
Denominator
Weighted average				17,654,684	$	0.68				17,531,414	$	0.43
Diluted EPS:
Numerator
Net income attributable to Turning Point Brands, Inc.	$	12,010					$	7,597
Interest expense related to Convertible Senior Notes, net of tax		731						954
Diluted net income attributable to Turning Point Brands. Inc.	$	12,741					$	8,551
Denominator
Basic weighted average				17,654,684						17,531,414
Convertible Senior Notes				2,218,018						3,029,699
Stock options and restricted stock units				297,612						108,039
				20,170,314	$	0.63				20,669,152	$	0.41

Note 16. Segment Information

In accordance with ASC 280, Segment Reporting, the Company has three reportable segments, (1) Zig-Zag Products; (2) Stoker’s Products; and (3) Creative Distribution Solutions. The Zig-Zag Products segment markets and distributes (a) rolling papers, tubes, and related products; (b) finished cigars and MYO cigar wraps and (c) CLIPPER reusable lighters and other accessories. The Stoker’s Products segment (a) manufactures and markets moist snuff and (b) contracts for and markets loose-leaf chewing tobacco products. The Creative Distribution Solutions segment (a) markets and distributes liquid nicotine products and certain other products without tobacco and/or nicotine; (b) distributes a wide assortment of products to non-traditional retail outlets via Vapor Beast; and (c) markets and distributes a wide assortment of products to individual consumers via the VaporFi B2C online platform. Products in the Zig-Zag Products and Stoker’s Products segments are distributed primarily through wholesale distributors in the U.S. and Canada while products in the Creative Distribution Solutions segment are distributed primarily through e-commerce to non-traditional retail outlets and direct to consumers in the U.S. Corporate unallocated includes the costs and assets of the Company not assigned to one of the three reportable segments such as intercompany transfers, deferred taxes, deferred financing fees, and investments in subsidiaries.

The accounting policies of these segments are the same as those of the Company. Corporate costs are not directly charged to the three reportable segments in the ordinary course of operations. The Company evaluates the performance of its segments and allocates resources to them based on operating income.

The tables below present financial information about reported segments:

	Three Months Ended<br><br> <br>March 31,
	2024			2023
Net sales
Zig-Zag products	$	46,697		$	41,887
Stoker’s products		36,367			33,662
Total Zig-Zag and Stoker’s products	$	83,064		$	75,549
Creative Distribution Solutions		13,994			25,407
Total	$	97,058		$	100,956
Gross profit
Zig-Zag products	$	27,538		$	22,390
Stoker’s products		20,815			19,465
Total Zig-Zag and Stoker’s products	$	48,353		$	41,855
Creative Distribution Solutions		3,559			6,762
Total	$	51,912		$	48,617
Operating income (loss)
Zig-Zag products	$	18,000		$	13,641
Stoker’s products		15,396			14,563
Corporate unallocated ^(1)(2)^		(14,127	)		(10,623	)
Total Zig-Zag and Stoker’s products	$	19,269		$	17,581
Creative Distribution Solutions		(3	)		261
Total	$	19,266		$	17,842
Interest expense, net		3,479			4,010
Investment (income) loss		(119	)		4,799
Gain on extinguishment of debt		–			(777	)
Income before income taxes	$	15,906		$	9,810
Capital expenditures
Zig-Zag products	$	166		$	973
Stoker’s products		200			1,462
Total Zig-Zag and Stoker’s products	$	366		$	2,435
Creative Distribution Solutions		–			–
Total	$	366		$	2,435
Depreciation and amortization
Zig-Zag products	$	274		$	267
Stoker’s products		879			706
Total Zig-Zag and Stoker’s products	$	1,153		$	973
Creative Distribution Solutions		570			574
Total	$	1,723		$	1,547
(1)	Includes corporate costs that are not allocated to any of the three reportable segments.
---	---
(2)	Includes costs related to PMTA of $0.8 million in 2024 and $0.1<br> million in 2023.
---	---

	March 31,		December 31,
	2024		2023
Assets
Zig-Zag products	$	176,629	$	177,135
Stoker’s products		187,794		174,994
Corporate unallocated ^(1)^		194,702		190,223
Total Zig-Zag and Stoker’s products	$	559,125	$	542,352
Creative Distribution Solutions		27,191		27,004
Total	$	586,316	$	569,356
(1)	Includes assets not assigned to the three reportable segments. All goodwill has been allocated to the reportable segments.
---	---

Revenue

  Disaggregation—Sales Channel

Revenues of the Zig-Zag Products and Stoker’s Products segments are primarily comprised of sales made to wholesalers while Creative Distribution Solutions sales are made business to business and business to consumer, both online and through our corporate retail stores. Creative Distribution Solutions net sales are broken out by sales channel below.

	Creative Distribution<br><br> <br>Solutions Segment
	Three Months Ended
	March 31,
	2024		2023
Business to Business	$	12,585	$	22,493
Business to Consumer - Online		1,380		2,810
Other		29		104
Total	$	13,994	$	25,407

Net

  Sales—Domestic vs. Foreign

The following table shows a breakdown of consolidated net sales between domestic and foreign customers.

	Three Months Ended
	March 31,
	2024		2023
Domestic	$	89,910	$	93,860
Foreign		7,148		7,096
Total	$	97,058	$	100,956

Note 17. Additional Information with Respect to Unrestricted Subsidiary

Under the terms of the Senior Secured Notes Indenture and Senior Secured Notes, the Company has designated its subsidiaries, South Beach Brands LLC, TPB Beast LLC and Intrepid Brands, LLC as “Unrestricted Subsidiaries”. South Beach Brands LLC is a holding company under which our vape business TPB Beast LLC operating as Creative Distribution Solutions sits. The Company is required under the terms of the Senior Secured Notes Indenture and the Senior Secured Notes to present additional information that reflects the financial condition and results of operations of the Company and its Restricted Subsidiaries separate from the financial condition and results of operations of the Company’s Unrestricted Subsidiaries as of and for the periods presented. This additional information is below.

Income Statement for the Three Months Ended March 31, 2024 and 2023 (unaudited):

	Three Months Ended March 31
	2024									2023
	Company and<br><br> <br>Restricted<br><br> <br>Subsidiaries			Unrestricted<br><br> <br>Subsidiaries			Consolidated			Company and<br><br> <br>Restricted<br><br> <br>Subsidiaries			Unrestricted<br><br> <br>Subsidiaries		Consolidated
Net sales	$	83,064		$	13,994		$	97,058		$	75,549		$	25,407	$	100,956
Cost of sales		34,711			10,435			45,146			33,694			18,645		52,339
Gross profit		48,353			3,559			51,912			41,855			6,762		48,617
Selling, general, and administrative expenses		29,084			3,562			32,646			24,274			6,501		30,775
Operating income (loss)		19,269			(3	)		19,266			17,581			261		17,842
Interest expense, net		3,479			–			3,479			4,010			–		4,010
Investment (gain) loss		(119	)		–			(119	)		4,799			–		4,799
Gain on extinguishment of debt		–			–			–			(777	)		–		(777	)
Income (loss) before income taxes		15,909			(3	)		15,906			9,549			261		9,810
Income tax expense (benefit)		3,728			(1	)		3,727			2,402			66		2,468
Consolidated net income (loss)		12,181			(2	)		12,179			7,147			195		7,342
Net income (loss) attributable to non-controlling interest		169			–			169			(255	)		–		(255	)
Net income (loss) attributable to Turning Point Brands, Inc.	$	12,012		$	(2	)	$	12,010		$	7,402		$	195	$	7,597

Balance Sheet as of March 31, 2024 (unaudited):

ASSETS	Company and<br><br> <br>Restricted<br><br> <br>Subsidiaries		Unrestricted<br><br> <br>Subsidiaries		Eliminations			Consolidated
Current assets:
Cash	$	126,066	$	4,837	$	–		$	130,903
Accounts receivable, net		8,198		–		–			8,198
Inventories, net		99,381		6,086		–			105,467
Other current assets		32,836		1,601		–			34,437
Total current assets		266,481		12,524		–			279,005
Property, plant, and equipment, net		24,705		85		–			24,790
Deferred income taxes		1,426		–		–			1,426
Right of use assets		10,764		104		–			10,868
Deferred financing costs, net		2,305		–		–			2,305
Goodwill		136,365		–		–			136,365
Other intangible assets, net		66,199		13,978		–			80,177
Master Settlement Agreement (MSA) escrow deposits		28,427		–		–			28,427
Other assets		22,453		500		–			22,953
Investment in unrestricted subsidiaries		62,732		–		(62,732	)		–
Total assets	$	621,857	$	27,191	$	(62,732	)	$	586,316
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	18,596	$	338	$	–		$	18,934
Accrued liabilities		29,618		1,356		–			30,974
Current portion of long-term debt		59,397		–		–			59,397
Total current liabilities		107,611		1,694		–			109,305
Notes payable and long-term debt		306,496		–		–			306,496
Lease liabilities		9,327		33		–			9,360
Total liabilities		423,434		1,727		–			425,161
Commitments and contingencies
Stockholders’ equity:
Total Turning Point Brands, Inc. Stockholders’ Equity/Net parent investment in unrestricted subsidiaries		197,232		25,464		(62,732	)		159,964
Non-controlling interest		1,191		–		–			1,191
Total stockholders’ equity		198,423		25,464		(62,732	)		161,155
Total liabilities and stockholders’ equity	$	621,857	$	27,191	$	(62,732	)	$	586,316

Balance Sheet as of December 31, 2023:

ASSETS	Company and<br><br> <br>Restricted<br><br> <br>Subsidiaries		Unrestricted<br><br> <br>Subsidiaries		Eliminations			Consolidated
Current assets:
Cash	$	116,725	$	1,161	$	–		$	117,886
Accounts receivable, net		9,989		–		–			9,989
Inventories, net		91,679		7,281		–			98,960
Other current assets		36,937		3,844		–			40,781
Total current assets		255,330		12,286		–			267,616
Property, plant, and equipment, net		25,142		158		–			25,300
Deferred income taxes		1,468		–		–			1,468
Right of use assets		11,359		121		–			11,480
Deferred financing costs, net		2,450		–		–			2,450
Goodwill		136,250		–		–			136,250
Other intangible assets, net		66,490		14,452		–			80,942
Master Settlement Agreement (MSA) escrow deposits		28,684		–		–			28,684
Other assets		15,166		–		–			15,166
Investment in unrestricted subsidiaries		48,229		–		(48,229	)		–
Total assets	$	590,568	$	27,017	$	(48,229	)	$	569,356
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	7,781	$	626	$	–		$	8,407
Accrued liabilities		32,052		1,583		–			33,635
Current portion of long-term debt		58,294		–		–			58,294
Total current liabilities		98,127		2,209		–			100,336
Notes payable and long-term debt		307,064		–		–			307,064
Lease liabilities		9,898		52		–			9,950
Total liabilities		415,089		2,261		–			417,350
Commitments and contingencies
Stockholders’ equity:
Total Turning Point Brands, Inc. Stockholders’ Equity/Net parent investment in unrestricted subsidiaries		174,449		24,756		(48,229	)		150,976
Non-controlling interest		1,030		–		–			1,030
Total stockholders’ equity		175,479		24,756		(48,229	)		152,006
Total liabilities and stockholders’ equity	$	590,568	$	27,017	$	(48,229	)	$	569,356

Note 18. Dividends and Share Repurchases

A dividend of $0.07 per common share was paid on April 12, 2024, to shareholders of record at the close of business on March 22, 2024.

The Company currently pays a quarterly cash dividend. Dividends are considered restricted payments under the Senior Secured Notes Indenture. The Company is generally permitted to make restricted payments provided that, at the time of payment, or as a result of payment, the Company is not in default on its debt covenants. Additional earnings and market capitalization restrictions limit the aggregate amount of restricted, quarterly dividends during a fiscal year.

On February 25, 2020, the Company’s Board of Directors approved a $50.0 million share repurchase program which is intended for opportunistic execution based upon a variety of factors including market dynamics. The program is subject to the ongoing discretion of the Board of Directors. On October 25, 2021, the Board of Directors increased the approved share repurchase program by $30.7 million and by an additional $24.6 million on February 24, 2022, in each case bringing the aggregate approval back to $50.0 million. In the first quarter of 2024, the Company repurchased $2.1 million of common stock, with $25.1 million remaining available for share repurchases under the program at March 31, 2024.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion of the historical financial conditions and results of operations in conjunction with our consolidated financial statements and accompanying notes, which are included elsewhere in this Quarterly Report on Form 10-Q. In addition, this discussion includes forward-looking statements which are subject to risks and uncertainties that may result in actual results differing from statements we make. See “Cautionary Note Regarding Forward-Looking Statements.” Factors that could cause actual results to differ include those risks and uncertainties discussed in “Risk Factors.”

The following Management’s Discussion and Analysis (“MD&A”) relates to the unaudited financial statements of Turning Point Brands, Inc., included elsewhere in this Quarterly Report on Form 10-Q. The MD&A is intended to enable the reader to understand the Company’s financial condition and results of operations, including any material changes in the Company’s financial condition and results of operations since December 31, 2023, and as compared with the three months ended March 31, 2023. The MD&A is provided as a supplement to and should be read in conjunction with the unaudited consolidated financial statements and notes thereto included in this Quarterly report on Form 10-Q, as well as “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained in the Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “2023 Annual Report”).

In this MD&A, unless the context requires otherwise, references to “our Company” “we,” “our,” or “us” refer to Turning Point Brands, Inc., and its consolidated subsidiaries. References to “TPB” refer to Turning Point Brands, Inc., without any of its subsidiaries. We were incorporated in 2004 under the name North Atlantic Holding Company, Inc. On November 4, 2015, we changed our name to Turning Point Brands, Inc. Many of the amounts and percentages in this discussion have been rounded for convenience of presentation.

Overview

Turning Point Brands, Inc. is a leading manufacturer, marketer and distributor of branded consumer products. We sell a wide range of products to adult consumers consisting of staple products with

        our iconic brands Zig-Zag® and Stoker’s® and our next generation products to fulfill evolving consumer preferences. Among other markets, we compete in the alternative smoking
        accessories and Other Tobacco Products \(“OTP”\) industries. The alternative smoking accessories market is a dynamic market experiencing robust secular growth driven by cannabinoid legalization in the U.S. and Canada, and positively evolving
        consumer perception and acceptance in North America. The OTP industry, which consists of non-cigarette tobacco products, exhibited low-single-digit consumer unit annualized growth over the four-year period ended 2023 as reported by Management
        Science Associates, Inc. a third-party analytics and information company. Our segments are led by our core proprietary and iconic brands: Zig-Zag® and CLIPPER® in the Zig-Zag Products segment and Stoker’s®
        along with Beech-Nut® and Trophy® in the Stoker’s Products segment. Our businesses generate solid cash flow which we use to invest in our business, finance acquisitions, increase brand support,
        expand our distribution infrastructure, and strengthen our capital position. We currently ship to approximately 820 distributors with an additional 650 secondary, indirect wholesalers in the U.S. that carry and sell our products. Under the
        leadership of a senior management team with extensive experience in the consumer products, alternative smoking accessories and tobacco industries, we have grown and diversified our business through new product launches, category expansions, and
        acquisitions while concurrently improving operational efficiency.

We believe there are meaningful opportunities to grow through investing in organic growth, acquisitions and joint ventures across all product categories. Our products are currently available in approximately 197,000 U.S. retail locations which, with the addition of retail stores in Canada, brings our total North American retail presence to an estimated 217,000 points of distribution. Our sales team targets widespread distribution to all traditional retail channels, including convenience stores, and we have a growing e-commerce business.

Products

We operate in three segments: Zig-Zag Products, Stoker’s Products and Creative Distribution Solutions. In our Zig-Zag Products segment, we principally market and distribute (i) rolling papers, tubes, and related products; (ii) finished cigars and make-your-own (“MYO”) cigar wraps; and (iii) CLIPPER reusable lighters and other accessories. In addition, we have a majority stake in Turning Point Brands Canada which is a specialty marketing and distribution firm focused on building brands in the Canadian cannabis accessories, tobacco and alternative products categories. In our Stoker’s Products segment, we (i) manufacture and market moist snuff tobacco (“MST”) and (ii) contract for and market loose leaf chewing tobacco products. In our Creative Distribution Solutions segment, we (i) market and distribute liquid nicotine products and certain other products without tobacco and/or nicotine; (ii) distribute a wide assortment of products to non-traditional retail via VaporBeast; and (iii) market and distribute a wide assortment of products to individual consumers via the VaporFi B2C online platform.

Operations

Our core Zig-Zag Products and Stoker’s Products segments primarily generate revenues from the sale of our products to wholesale distributors who, in turn, resell the products to retail operations. Our acquisition of Vapor Beast in 2016 expanded our revenue streams as we began selling directly to non-traditional retail outlets. Our acquisition of IVG in 2018 enhanced our B2C revenue stream with the addition of the Vapor-Fi online platform. Our net sales, which include federal excise taxes, consist of gross sales net of cash discounts, returns, and selling and marketing allowances.

We rely on long-standing relationships with high-quality, established manufacturers to provide the majority of our produced products. Approximately 75% of our production, as measured by net sales, is outsourced to suppliers. The remaining production consists primarily of our moist snuff tobacco operations located in Dresden, Tennessee and Louisville, Kentucky. Our principal operating expenses include the cost of raw materials used to manufacture the limited number of our products which we produce in-house; the cost of finished products, which are generally purchased goods; federal excise taxes; legal expenses; and compensation expenses, including benefits and costs of salaried personnel.

Key Factors Affecting Our Results of Operations

We consider the following to be the key factors affecting our results of operations:

●	Our ability to further penetrate markets with our existing products;
●	Our ability to introduce new products and product lines that complement our core business;
---	---
●	Decreasing interest in some tobacco products among consumers;
---	---
●	Price sensitivity in our end-markets;
---	---
●	Marketing and promotional initiatives, which cause variability in our results;
---	---
●	Costs and increasing regulation of promotional and advertising activities;
---	---
●	General economic conditions, including consumer access to disposable income and other conditions affecting purchasing power such as inflation and the interest rate environment;
---	---
●	Labor and production costs;
---	---
●	Cost of complying with regulation, including the “deeming regulation”;
---	---
●	Increasing and unpredictable regulation and/or marketing order decisions impacting Creative Distribution Solutions products;
---	---
●	Counterfeit and other illegal products in our end-markets;
---	---
●	Currency fluctuations;
---	---
●	Our ability to identify attractive acquisition opportunities; and
---	---
●	Our ability to successfully integrate acquisitions.
---	---

Critical Accounting Policies and Uses of Estimates

There have been no material changes to our critical accounting policies and estimates from the information provided in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our 2023 Annual Report on Form 10-K.

Recent Accounting Pronouncements

There are no recent accounting pronouncements that impact the Company.

Recent Developments

Non-Marketable Equity Investments

In January 2024, the Company invested $0.8 million in Teaza Energy, LLC (“TeaZa”), an innovative brand of flavorful oral pouch products designed as a healthier alternative to high energy drinks and other oral stimulants. The Company’s investment is comprised of $0.5 million in cash and a $0.3 million payable to be offset against the Company’s allocated portion of future profit distributions.

Results of Operations

Comparison of the Three Months Ended March 31, 2024, to the Three Months Ended March 31, 2023

The table and discussion set forth below displays our consolidated results of operations (in thousands):

	Three Months Ended March 31,
	2024			2023			% Change
Consolidated Results of Operations Data:
Net sales
Zig-Zag products	$	46,697		$	41,887			11.5	%
Stoker’s products		36,367			33,662			8.0	%
Total Zig-Zag and Stoker’s products		83,064			75,549			9.9	%
Creative Distribution Solutions		13,994			25,407			-44.9	%
Total net sales		97,058			100,956			-3.9	%
Cost of sales		45,146			52,339			-13.7	%
Gross profit
Zig-Zag products		27,538			22,390			23.0	%
Stoker’s products		20,815			19,465			6.9	%
Total Zig-Zag and Stoker’s products		48,353			41,855			15.5	%
Creative Distribution Solutions		3,559			6,762			-47.4	%
Total gross profit		51,912			48,617			6.8	%
Selling, general, and administrative expenses		32,646			30,775			6.1	%
Operating income		19,266			17,842			8.0	%
Interest expense, net		3,479			4,010			-13.2	%
Investment (gain) loss		(119	)		4,799			-102.5	%
Gain on extinguishment of debt		–			(777	)	NM
Income before income taxes		15,906			9,810			62.1	%
Income tax expense		3,727			2,468			51.0	%
Consolidated net income		12,179			7,342			65.9	%
Net income (loss) attributable to non-controlling interest		169			(255	)		-166.3	%
Net income attributable to Turning Point Brands, Inc.	$	12,010		$	7,597			58.1	%

Net Sales: For the three months ended March 31, 2024, consolidated net sales decreased to $97.1 million from $101.0 million for the three months ended March

      31, 2023, a decrease of $3.9 million or 3.9%.

For the three months ended March 31, 2024, net sales in the Zig-Zag Products segment increased to $46.7 million from $41.9 million for the three months ended March 31, 2023, an increase of $4.8 million or 11.5%. The increase in net sales was driven by growth in our U.S. papers and wraps businesses, partially offset by declines in sales in our Clipper business against trade load in prior year.

For the three months ended March 31, 2024, net sales in the Stoker’s Products segment increased to $36.4 million from $33.7 million for the three months ended March 31, 2023, an increase of $2.7

      million or 8.0%. For the three months ended March 31, 2024, volume increased 0.1% and price/product mix increased 7.9%. The increase in net sales was driven by mid-single-digit growth of Stoker’s® MST and triple-digit growth of our modern oral product FRE, partially offset by mid-single-digit decline in loose-leaf chewing tobacco.

For the three months ended March 31, 2024, net sales in the Creative Distribution Solutions segment decreased to $14.0 million from $25.4 million for the three months ended March 31, 2023, a decrease of $11.4 million or 44.9%. The decrease in net sales was primarily the result of lower volumes in the liquid nicotine distribution business and our strategic decision to eliminate certain unprofitable brands and to focus on a narrower set of products.

Gross Profit: For the three months ended March 31, 2024, consolidated gross profit increased to $51.9 million from $48.6 million for the three months ended

      March 31, 2023, an increase of $3.3 million or 6.8%. Gross profit as a percentage of net sales increased to 53.5% for the three months ended March 31, 2024, compared to 48.2% for the three months ended March 31, 2023 driven by product mix in our
      Zig-Zag Products segment.

For the three months ended March 31, 2024, gross profit in the Zig-Zag Products segment increased to $27.5 million from $22.4 million for the three months ended March 31, 2023, an increase of $5.1 million or 23.0%. Gross profit as a percentage of net sales increased to 59.0% of net sales for the three months ended March 31, 2024, from 53.5% of net sales for the three months ended March 31, 2023, driven primarily by product mix.

For the three months ended March 31, 2024, gross profit in the Stoker’s Products segment increased to $20.8 million from $19.5 million for the three months ended March 31, 2023, an increase of $1.3 million or 6.9%. Gross profit as a percentage of net sales decreased to 57.2% of net sales for the three months ended March 31, 2024, from 57.8% of net sales for the three months ended March 31, 2023, primarily as a result of product mix, as net sales of FRE were higher and have lower margins than other products in the segment.

For the three months ended March 31, 2024, gross profit in the Creative Distribution Solutions segment decreased to $3.6 million from $6.8 million for the three months ended March 31, 2023, a decrease of $3.2 million or 47.4%. Gross profit as a percentage of net sales decreased to 25.4% of net sales for the three months ended March 31, 2024, from 26.6% of net sales for the three months ended March 31, 2023, primarily as a result of channel mix and our strategic decision to eliminate certain unprofitable brands and to focus on a narrower set of products.

Selling, General, and Administrative Expenses: For the three months ended March 31, 2024, selling, general, and administrative expenses increased to $32.6

      million from $30.8 million for the three months ended March 31, 2023, an increase of $1.9 million or 6.1%. Selling, general and administrative expenses in the three months ended March 31, 2024, included $2.1 million of stock options, restricted
      stock and incentives expense, $0.8 million of expense related to PMTA, $1.3 million of expense related to corporate restructuring, and $0.1 million of expense related to the new ERP and CRM systems. Selling, general and administrative expenses in
      the three months ended March 31, 2023, included $0.7 million of stock options, restricted stock and incentives expense, $0.2 million of expense related to PMTA and $0.1 million of consulting expense related to the scoping and mobilization of the
      new ERP and CRM systems.

Interest Expense, net: For the three months ended March 31, 2024, interest expense, net decreased to $3.5 million from $4.0 million for the three months

      ended March 31, 2023 as a result of increased interest income on cash deposits as a result of rising interest rates.

Investment (Gain) Loss: For the three months ended March 31, 2024, we had an investment gain of $0.1 million compared to a $4.8 million loss for the three

      months ended March 31, 2023. The change is a result of an impairment charge recognized on our investment in Docklight for $4.9 million in the first quarter of 2023.

Gain on Extinguishment of Debt: There was no gain or loss on extinguishment of debt for the three months ended March 31, 2024 compared to a $0.8 million gain

      for the three months ended March 31, 2023 as a result of repurchasing $13.9 million of Convertible Senior Notes in the first quarter of 2023.

Income Tax Expense: Our income tax expense of $3.7 million was 23.4% of income before income taxes for the three months ended March 31, 2024. Our effective

      income tax rate was 25.2% for the three months ended March 31, 2023.

Net Income (Loss) Attributable to Non-Controlling Interest: Net gain attributable to non-controlling interest was $0.2 million for the three months ended

      March 31, 2024 compared to $0.3 million net loss for the three months ended March 31, 2023.

Net Income Attributable to Turning Point Brands, Inc.: Due to the factors described above, net income attributable to Turning Point Brands, Inc. for the

      three months ended March 31, 2024 and 2023, was $12.0 million and $7.6 million, respectively.

EBITDA and Adjusted EBITDA

To supplement our financial information presented in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, we use non-U.S. GAAP financial measures including EBITDA and Adjusted EBITDA. We believe Adjusted EBITDA provides useful information to management and investors regarding certain financial and business trends relating to our financial condition and results of operations. Adjusted EBITDA is used by management to compare our performance to that of prior periods for trend analyses and planning purposes and is presented to our Board of Directors. We believe that EBITDA and Adjusted EBITDA are appropriate measures of operating performance because they eliminate the impact of expenses that do not relate to operating performance. In addition, our debt instruments contain covenants which use Adjusted EBITDA calculations.

We define “EBITDA” as net income before interest expense, gain (loss) on extinguishment of debt, provision for income taxes, depreciation, and amortization. We define “Adjusted EBITDA” as net income before interest expense, gain (loss) on extinguishment of debt, provision for income taxes, depreciation, amortization, other non-cash items, and other items we do not consider the ordinary course in our evaluation of ongoing operating performance noted in the reconciliation below.

Non-U.S. GAAP measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with U.S. GAAP. Adjusted EBITDA excludes significant expenses required to be recorded in our financial statements by U.S. GAAP and is subject to inherent limitations. Other companies in our industry may calculate this non-U.S. GAAP measure differently than we do or may not calculate it at all, limiting its usefulness as a comparative measure. The tables below provide reconciliations between net income and Adjusted EBITDA.

(in thousands)	Three Months Ended<br><br> <br>March 31,
	2024		2023
Net income attributable to Turning Point Brands, Inc.	$	12,010	$	7,597
Add:
Interest expense, net		3,479		4,010
Gain on extinguishment of debt		–		(777	)
Income tax expense		3,727		2,468
Depreciation expense		837		776
Amortization expense		886		771
EBITDA	$	20,939	$	14,845
Components of Adjusted EBITDA
Corporate and CDS restructuring (a)		1,261		–
ERP/CRM (b)		138		138
Stock options, restricted stock, and incentives expense (c)		2,062		743
Transactional expenses and strategic initiatives (d)		30		4
FDA PMTA (e)		841		158
Non-cash asset impairment (f)		–		4,897
Adjusted EBITDA	$	25,271	$	20,785
(a)	Represents costs associated with corporate and CDS restructuring, including severance.
---	---
(b)	Represents cost associated with scoping and mobilization of new ERP and CRM systems and cost of duplicative ERP licenses.
---	---
(c)	Represents non-cash stock options, restricted stock, incentives expense and Solace performance stock units.
---	---
(d)	Represents the fees incurred for transaction expenses.
---	---
(e)	Represents costs associated with applications related to FDA premarket tobacco product application (“PMTA”).
---	---
(f)	Represents impairment of investment assets.
---	---

Liquidity and Capital Resources

As of March 31, 2024, we have $130.9 million of cash on hand and have $59.0 million of availability under the 2023 ABL Facility. Our principal uses for cash are working capital, debt service, and capital expenditures.

Our Convertible Senior Notes, with an outstanding balance of $118.5 million as of March 31, 2024, mature in July 2024. On November 7, 2023, one of our wholly-owned subsidiaries entered into the 2023 ABL Facility to refinance up to $75.0 million of the Convertible Senior Notes at maturity. As a result, we classified $59.0 million (our current availability under the 2023 ABL Facility based on borrowing base calculations) related to the Convertible Senior Notes in long-term liabilities on our March 31, 2024 Consolidated Balance Sheet. With our strong cash balance, free cash flow generation and borrowing availability under the 2023 ABL Facility, we expect to have ample liquidity to address the remaining balance of the Convertible Senior Notes maturing in July, and to satisfy our operating cash requirements for the foreseeable future.

Our working capital, which we define as current assets less cash and current liabilities, decreased to $38.8 million at March 31, 2024, compared with $49.4 million at December 31, 2023. The decrease in working capital is primarily a result of the timing of inventory payments as well as $3.0 million insurance deposits being invested in investments.

	As of
(in thousands)	March 31,<br><br> <br>2024		December 31,<br><br> <br>2023
Current assets	$	148,102	$	149,730
Current liabilities		109,305		100,336
Working capital	$	38,797	$	49,394

Cash Flows from Operating Activities

For the three months ended March 31, 2024, net cash provided by operating activities was $22.6 million compared to net cash provided by operating activities of $15.4 million for the three months ended March 31, 2023, an increase of $7.2 million, primarily due to the timing of changes in other working capital and net income from operations.

Cash Flows from Investing Activities

For the three months ended March 31, 2024, net cash used in investing activities was $8.0 million compared to net cash used in investing activities of $2.4 million for the three months ended March 31, 2023, an increase in cash used in investing activities of $5.6 million, primarily due to an increase in purchases of captive insurance investments.

Cash Flows from Financing Activities

For the three months ended March 31, 2024, net cash used in financing activities was $4.6 million compared to net cash used in financing activities of $14.6 million for the three months ended March 31, 2023, a decrease of $10.0 million, primarily due to an increase in repurchases of common stock of $2.1 million during the period, offset by $13.0 million in repurchases of Convertible Senior Notes during the same period in 2023.

Dividends and Share Repurchase

A dividend of $0.07 per common share was paid on April 12, 2024, to shareholders of record at the close of business on March 22, 2024.

On February 25, 2020, our Board of Directors approved a $50.0 million share repurchase program, which is intended for opportunistic execution based upon a variety of factors including market dynamics. The program is subject to the ongoing discretion of the Board of Directors. On October 25, 2021, the Board of Directors increased the approved share repurchase program by $30.7 million and by an additional $24.6 million on February 24, 2022. In the first quarter of 2024, the Company repurchased $2.1 million of common stock, with $25.1 million remaining available for share repurchases under the program as of March 31, 2024.

Long-Term Debt

Notes payable and long-term debt consisted of the following at March 31, 2024 and December 31, 2023, in order of preference:

	March 31,<br><br> <br>2024			December 31,<br><br> <br>2023
Senior Secured Notes	$	250,000		$	250,000
Convertible Senior Notes		118,541			118,541
Gross notes payable and long-term debt		368,541			368,541
Less deferred finance charges		(2,648	)		(3,183	)
Less current maturities		(59,397	)		(58,294	)
Notes payable and long-term debt	$	306,496		$	307,064

Senior Secured Notes

On February 11, 2021, we closed a private offering (the “Offering”) of $250 million aggregate principal amount of our 5.625% senior secured notes due 2026 (the “Senior Secured Notes”). The Senior Secured Notes bear interest at a rate of 5.625% and will mature on February 15, 2026. Interest on the Senior Secured Notes is payable semi-annually in arrears on February 15 and August 15 of each year, commencing on August 15, 2021.We used the proceeds from the Offering (i) to repay all obligations under and terminate the 2018 First Lien Credit Facility, (ii) to pay related fees, costs, and expenses and (iii) for general corporate purposes.

The Company may redeem the Senior Secured Notes, in whole or in part, at any time, at the redemption prices (expressed as a percentage of the principal amount to be redeemed) set forth below, plus accrued and unpaid interest, if any, on the Senior Secured Notes to be redeemed to (but not including) the applicable redemption date if redeemed during the period indicated below:

On or after February 15, 2023	102.813	%
On or after February 15, 2024	101.406	%
On or after February 15, 2025 and thereafter	100.000	%

If we experience a change of control (as defined in the Senior Secured Notes Indenture), we must offer to repurchase the Senior Secured Notes at a repurchase price equal to 101% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest.

The Senior Secured Notes Indenture contains covenants that, among other things, restrict the ability of the Company and its restricted subsidiaries to: (i) grant or incur liens; (ii) incur, assume or guarantee additional indebtedness; (iii) sell or otherwise dispose of assets, including capital stock of subsidiaries; (iv) make certain investments; (v) pay dividends, make distributions or redeem or repurchase capital stock; (vi) engage in certain transactions with affiliates; and (vii) consolidate or merge with or into, or sell substantially all of our assets to another entity. These covenants are subject to a number of limitations and exceptions set forth in the Senior Secured Notes Indenture. The Senior Secured Notes Indenture provides for customary events of default. We were in compliance with all covenants as of March 31, 2024.

We incurred debt issuance costs attributable to the issuance of the Senior Secured Notes of $6.4 million which are amortized to interest expense using the straight-line method over the expected life of the Senior Secured Notes.

2021 Revolving Credit Facility

In connection with the Offering, we also entered into a $25.0 million senior secured revolving credit facility (the “2021 Revolving Credit Facility”) with the lenders party thereto and Barclays Bank PLC, as administrative agent and collateral agent (in such capacity, the “Agent”). This facility was terminated in November 2023 in connection with the entry by a subsidiary of the Company in a new asset-backed revolving credit facility. See “2023 ABL Facility” below. We incurred debt issuance costs attributable to the issuance of the 2021 Revolving Credit Facility of $0.5 million, with the remaining $0.2 million written off to gain on debt extinguishment upon termination of the facility.

2023 ABL Facility

Amounts borrowed under the 2023 ABL Facility are subject to an interest rate margin per annum equal to (a) from and after the closing date until the last day of the first full fiscal quarter ended after the closing date, (i) 1.25% per annum, in the case base rate loans, and (ii) 2.25% per annum, in the case of revolving credit loans that are SOFR Loans, (b)(i) 2.25% per annum, in the case of LILO loans that are base rate loans, and (ii) 3.25% per annum, in the case of LILO loans that are SOFR loans, (c) on the first day of each fiscal quarter, the applicable interest rate margins will be determined from the pricing grid below based upon the historical excess availability for the most recent fiscal quarter ended immediately prior to the relevant date, as calculated by the Administrative Agent.

Level	Historical Excess Availability	Applicable Margin<br><br> <br>for SOFR Loans	Applicable Margin<br><br> <br>for Base Rate Loans
I	Greater than or equal to 66.66%	1.75%	0.75%
II	Less than 66.66%, but greater than or<br><br> <br>equal to 33.33%	2.00%	1.00%
III	Less than 33.33%	2.25%	1.25%

The 2023 ABL Facility will mature on the earlier of (x) November 7, 2027 and (y) the date that is 91 days prior to the maturity date of any material debt of the ABL Borrower or the Company or any of its restricted subsidiaries (subject to customary extensions agreed by the lenders thereunder); provided that clause (y) shall not apply to the extent that on any applicable date of determination (on any date prior to the date set forth in clause (y)), (A) the sum of (x) cash that is held in escrow for the repayment of such material debt pursuant to arrangements satisfactory to the Administrative Agent, (y) cash that is held in accounts with the Administrative Agent and/or the Additional Collateral Agent, plus (z) excess availability, is sufficient to repay such material debt and (B) the ABL Borrower has excess availability of at least $15.0 million after giving effect to such repayment of material debt, including any borrowings under the commitments in connection therewith.

Convertible Senior Notes

As discussed above, on November 7, 2023, a wholly-owned subsidiary of the Company entered into the 2023 ABL Facility to refinance up to $75.0 million of the Convertible Senior notes at maturity. As a result, the Company classified $59.0 million related to the Convertible Senior Notes in Notes payable and long-term debt on the Company’s March 31, 2024 Consolidated Balance Sheets. Based on current liquidity, free cash flow generation and availability under the 2023 ABL Facility, the Company believes it will have sufficient liquidity to address the maturity of the remaining Convertible Senior Notes.

Off-balance Sheet Arrangements

During the three months ended March 31, 2024, the Company executed no foreign exchange contracts meeting hedge accounting requirements. At March 31, 2024, we had foreign currency contracts outstanding for the purchase of €9.2 million and sale of €9.2 million, with maturities ranging from April to September 2024. The fair value of the foreign currency contracts were based on quoted market prices and resulted in an asset of $0.0 million included in Other current assets and a liability of $0.1 million included in Accrued liabilities at March 31, 2024. During 2023, we executed various foreign exchange contracts for the purchase of €20.1 million and sale of €15.2 million. At December 31, 2023, we had foreign currency contracts outstanding for the purchase of €15.2 million and sale of €15.2 million. The fair value of the foreign currency contracts were based on quoted market prices and resulted in an asset of $0.3 million included in Other current assets and a liability of $0.1 million included in Accrued liabilities at December 31, 2023.

Inflation

Inflation in general, coupled with increases in gas prices have had a substantial negative effect on the purchasing power of consumers. While historically, we have been able to increase prices at a rate equal to or greater than that of inflation, doing so would be difficult in the current inflationary environment. However, we have implemented price increases in areas where doing so has been feasible. In addition, we have been able to maintain a relatively stable variable cost structure for our products due, in part, to our successful procurement regarding our tobacco products and, in part, to our existing contractual agreement for the purchase of our premium cigarette papers.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Foreign Currency Sensitivity

During the quarter ended March 31, 2024, there have been no material changes in our exposure to exchange rate fluctuation risk, as reported within our 2023 Annual Report on Form 10-K. Please refer to our ‘Quantitative and Qualitative Disclosures about Market Risk’ included in our 2023 Annual Report on Form 10-K filed with the SEC.

Credit Risk

There have been no material changes in our exposure to credit risk, as reported within our 2023 Annual Report on Form 10-K, during the three months ended March 31, 2024. Please refer to our ‘Quantitative and Qualitative Disclosures about Market Risk’ included in our 2023 Annual Report on Form 10-K filed with the SEC.

Interest Rate Sensitivity

In February 2021, we issued the Senior Secured Notes in an aggregate principal amount of $250 million. In July 2019, we issued Convertible Senior Notes in an aggregate principal amount of $172.5 million. We carry the Senior Secured Notes and Convertible Senior Notes at face value. Since the Senior Secured Notes and Convertible Senior Notes bear interest at a fixed rate, we have no financial statement risk associated with changes in interest rates. However, the fair value of the Convertible Senior Notes changes when the market price of our stock fluctuates, or interest rates change. Our remaining debt instrument is a revolving credit facility, which has no borrowing outstanding.

Item 4. Controls and Procedures

We have carried out an evaluation under the supervision, and with the participation of, our management including our Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”), and Chief Accounting Officer (“CAO”), of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act of 1934), as of March 31, 2024. Based upon the evaluation, our CEO, CFO, and CAO concluded our disclosure controls and procedures are not effective as of such date solely due to material weaknesses in internal controls over financial reporting that were disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023.

As previously described in Part II, Item 9A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, during our evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2023, we concluded that our internal control over financial reporting was not effective solely due to the existence of the following material weakness:

We did not design and maintain effective internal controls related to our information technology general controls (“ITGCs”) in the areas of user access and program change-management over certain information technology (“IT”) systems that support the Company’s financial reporting processes. Our business process controls (automated and manual) that are dependent on the affected ITGCs were also deemed ineffective because they could have been adversely impacted. We believe that these control deficiencies were a result of: IT control processes lacking sufficient documentation such that the successful operation of ITGCs was overly dependent upon knowledge and actions of certain individuals with IT expertise and inherent system limitations.

The material weakness did not result in any identified misstatements to our financial statements, and there were no changes to previously released financial results. The material weakness will not be considered remediated until the applicable controls operate for a sufficient period of time, and management has concluded through testing that these controls are operating effectively.

Remediation Plan

While our remediation plan may evolve and expand, management has been implementing and continues to implement measures designed to ensure that control deficiencies contributing to the material weakness are remediated, such that these controls are designed, implemented, and operating effectively. The remediation actions include: (i) implementation of a new ERP system in 2024; (ii) developing and maintaining documentation underlying ITGCs; (iii) implementing an IT management review and testing plan to monitor ITGCs with a specific focus on systems supporting our financial reporting processes; and (iv) enhanced quarterly reporting on the remediation measures to the Audit Committee of the Board of Directors.

We believe that these actions will remediate the material weakness. The material weakness will not be considered remediated, however, until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

For a description of our material pending legal proceedings, please see Contingencies in Note 14 to the Notes to the Consolidated Financial Statements in Part I, Item 1 of this Quarterly Report.

See ‘Risk Factors—We are subject to significant product liability litigation’ within our 2023 Annual Report on Form 10-K for additional details.

Item 1A. Risk Factors

In addition to the other information set forth in this report, carefully consider the factors discussed in the ‘Risk Factors’ section contained in our 2023 Annual Report on Form 10-K. There have been no material changes to the Risk Factors set forth in the 2023 Annual Report on Form 10-K.

Item 2. Unregistered

              Sales of Equity Securities and Use of Proceeds

On February 25, 2020, the Company’s Board of Directors approved a $50.0 million share repurchase program, which is intended for opportunistic execution based upon a variety of factors including market dynamics. On October 25, 2021, the Board of Directors increased the approved share repurchase program by $30.7 million bringing the authority at the time back to $50.0 million (including approximately $19.3 million available for repurchases under the Board of Directors’ previous authorization). On February 24, 2022, the Board of Directors increased the approved share repurchase program by $24.6 million bringing total authority at that time to $50.0 million. This share repurchase program has no expiration date and is subject to the ongoing discretion of the Board of Directors. All repurchases to date under our stock repurchase programs have been made through open market transactions, but in the future, we may also purchase shares through privately negotiated transactions or 10b5-1 repurchase plans.

The following table includes information regarding purchases of our common stock made by us during the quarter ended March 31, 2024 in connection with the repurchase program described above.

Period	Total Number<br><br> <br>of Shares<br><br> <br>Purchased ^(1)^		Average<br><br> <br>Price Paid<br><br> <br>per Share			Approximate Dollar<br><br> <br>Value of Shares<br><br> <br>that May Yet Be<br><br> <br>Purchased Under the<br><br> <br>Plans or Programs
January 1 to January 31		3,015	$	26.32	–	$	27,197,886
February 1 to February 29		39,429	$	24.84	–	$	27,197,886
March 1 to March 31		83,420	$	27.94	72,545	$	25,118,746
Total		125,864			72,545
(1)	The total number of shares purchased includes shares withheld by the Company in an amount equal to the statutory withholding taxes for holders who vested in stock-based awards, which totaled 3,015 shares in<br> January, 39,429 shares in February and 10,875 shares in March. Shares withheld by the Company to cover statutory withholdings taxes are repurchased pursuant to the applicable plan and not the authorization under the share repurchase<br> program.
---	---

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Not applicable.

Item 6. Exhibits

Exhibit No.	Description
10.1	Employment Agreement by and between the Company and Andrew Flynn, dated as of March 6, 2024 (incorporated herein by reference to Exhibit 10.1 of Turning Point Brands, Inc’s Current Report<br> on Form 8-K filed with the Commission on March 12, 2024 (File No. 001-37763)).
10.2	Employment Agreement by and between the Company and David Glazek, dated as of March 29, 2024.*
31.1	Rule 13a-14(a)/15d-14(a) Certification of Graham Purdy.*
31.2	Rule 13a-14(a)/15d-14(a) Certification of Andrew Flynn.*
31.3	Rule 13a-14(a)/15d-14(a) Certification of Brian Wigginton.*
32.1	Section 1350 Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
101	XBRL (eXtensible Business Reporting Language). The following materials from Turning Point Brands, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, filed on May 2,<br> 2024, formatted in Inline XBRL (iXBRL): (i) consolidated balance sheets, (ii) consolidated statements of income, (iii) consolidated statements of comprehensive income, (iv) consolidated statements of cash flows, and (v) the notes to<br> consolidated financial statements.*
104	Cover Page Interactive Data File (formatted in iXBRL and included in Exhibit 101).*
*	Filed or furnished herewith
---	---

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	TURNING POINT BRANDS, INC.
		By: /s/ Graham Purdy
		Name: Graham Purdy
		Title: President and Chief Executive Officer
		By: /s/ Andrew Flynn
		Name: Andrew Flynn
		Title: Chief Financial Officer
		By: /s/ Brian Wigginton
		Name: Brian Wigginton
		Title: Chief Accounting Officer
Date: May 2, 2024

Exhibit 10.2

Turning Point Brands, Inc.

5201 Interchange Way

Louisville, KY 40229

March 29, 2024

Dear David:

As discussed, the Board of Directors (the “Board”) of Turning Point Brands, Inc., together with any successor thereto (“Turning Point” and, together with its applicable employing subsidiaries, the “Company”)

    wishes to extend your service as Executive Chairman of Turning Point on the general terms, provisions and conditions set forth in this letter agreement \(the “Letter”\). If you find these terms, provisions and conditions acceptable, please
    sign this Letter where indicated and return to me as soon as possible.

Term: Your service as Executive Chairman will be for an initial term ending on December 31, 2025 (the “Initial Term”), unless terminated earlier by either party. Your employment period will be automatically renewed each year on January 1^st^ thereafter , unless either you or the Company provides the other with a written notice of non-renewal at least ninety (90) days prior to the applicable expiration date (the Initial Term and any renewal period(s) together, the “Term”).

Compensation: You will not receive an annual base salary for your service as Executive Chairman. For each calendar year commencing during the Term, in lieu of salary you will receive an equity award consisting of at least 50% time-based restricted stock units and 50% stock options having an aggregate grant date value of $1,000,000 (the “Annual Equity Award”). The Annual Equity Award will vest in quarterly installments during the Term. The Annual Equity Award will be subject to the terms and conditions of the Company’s equity incentive plan and shall be subject to the award agreement(s) attached hereto as Exhibit A. The Annual Equity Award for each calendar year shall be granted on January 1 or the first business day of that year, subject to any blackout restrictions. The Board or a committee thereof shall determine an appropriate target-level annual bonus or other opportunity for you in connection with its annual compensation-setting process and will consult with you on any applicable performance objectives/parameters. Performance-based or time-based awards granted under the Company’s Long-Term Incentive Plan (“LTIP”) to you and other eligible participants shall remain subject to those respective agreements, irrespective of treatment of the Annual Equity Award as contemplated by this Agreement.

Additional Benefits: You will be entitled to participate in the Company’s long-term equity incentive program as well as medical, dental and 401(k) savings benefit plans offered to the Company’s executives pursuant to the terms and conditions of each such plan in effect from time to time, which may be authorized, amended or discontinued by the Company in its sole discretion. The Company will provide a description of the benefit programs and enrollment forms.

Additional Terms and Conditions

1. Duties and Responsibilities: As Executive Chair, you will report to the full Board, and will be responsible for carrying out the duties and responsibilities described on Schedule A. You shall have all of the authority, and perform all of the functions, that are consistent with such position, subject to lawful direction by the Board. You will be subject to, and agree to abide by, such rules, policies and procedures as the Company maintains (including, but not limited to, the Turning Point Brands, Inc. Code of Business Conduct and Ethics (as amended from time to time, the “Code of Conduct and Ethics”)) or may from time to time establish with respect to executives, employees in general, standard operating procedures, business operations, etc.

2. Indemnification: The Company shall, to the fullest extent to which it is empowered to do so by applicable law, defend, indemnify and hold you harmless from and against all claims, demands, lawsuits, liabilities, losses, damages, penalties, fines, costs and expense (including, but not limited to, reasonable related attorneys’ fees) arising from any actual, threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative, investigative or otherwise, to which you are or are threatened to be made a party by reason of your services as an officer and/or director of the Company. Nothing in this Letter shall be deemed to preclude you from receiving any of the benefits or protections, including without limitation representation, available to you following any separation under (a) any officers and directors insurance policy maintained by the Company which provides coverage during your employment by the Company as an officer or director of the Company or (b) the Company’s bylaws, Certificate of Incorporation or under applicable law. Any such benefits and protections shall or shall not be provided solely in accordance with the terms and conditions of any such policies, documents and applicable law.

3. Amendment; Assignment: This Letter shall not be amended or modified except by written agreement signed by both parties. Any successor to the Company shall be obligated to assume and perform the terms of this Letter.

Severance Benefits: If the Term and your employment with the Company are terminated by the Company without Cause (as defined in paragraph 4.5), but excluding death or disability, or if your resign with Good Reason, or if the Company chooses not to renew the Term of this Agreement (a “Qualifying Termination”), you shall be entitled to receive the Severance Benefits described below (the “Severance Benefits”), provided that you have executed and delivered a Release and Severance Agreement in the form of Exhibit A attached hereto (as may be modified by the Company and reasonably acceptable to you due to subsequent changes in law), and all applicable revocation periods relating to the release expire, within 55 days following the date of such Separation.

4.1 Severance Benefits Period: A period of 12 months following a termination of your employment with the Company and its subsidiaries by the Company without Cause (other than death or disability) or resignation of your employment with the Company and its subsidiaries by you for Good Reason, other than within one year following a Change of Control. If you resign for Good Reason or are terminated by the Company without Cause (other than death or disability) within one year following a Change of Control, the Severance Benefits Period shall be a period of 24 months following such termination of employment.

4.2 Severance Compensation: Continuation of the cash equivalent of the grant date value of your Annual Equity Award during the Severance Benefits Period described above (“Severance Pay”). In the event of a Qualifying Termination within one year following a Change of Control, your Severance Pay shall instead be equal to two times the grant date value of your Annual Equity Award that would have otherwise been received by you during the 24 months following your Separation. The Severance Pay shall be paid in accordance with the Company’s regular payroll cycle, with the first such payment beginning on the 60th day following the Separation Date (the “Payment Date”). The first such payment will include all accrued amounts during the 60-day period from the Separation Date through the Payment Date.

4.3 Health Benefits Stipend and Access: Upon a Qualifying Termination, the Company will pay a lump sum payment to you in amount equal to the cost of the employer-portion of maintaining COBRA coverage based on rates in effect at the time of termination for you and your eligible dependents for 12 months, payable on the Payment Date.

4.4 Other Additional Benefits: In the event of a Qualifying Termination, any unvested portion of any Annual Equity Award granted prior to such Qualifying Termination, as well as any other equity-based awards held by you that are unvested as of the date of such Qualifying Termination, will be treated as fully vested and you shall be entitled to any and all ownership interests in said equity awards as if your termination of employment had not occurred. Your entitlement to actively participate as an employee in the Company’s health and welfare and retirement plans will cease upon your Separation, except as otherwise provided in this Agreement or the written terms of the applicable benefit plans.

As used herein, the term “Good Reason Event” means any of the following without your consent: (i) the Board requesting that you resign from the position of Executive Chairman (regardless of whether or not you remain on the Board) for a reason other than (x) your disability or (y) for Cause, (ii) a material diminution in your duties, position, authorities or responsibilities as Executive Chairman (including you no longer holding the position of Executive Chairman following a Change in Control); provided, that any alleged conflict with your duties, position, authorities or responsibilities and those of the Company’s CEO shall not give rise to Good Reason, (iii) you no longer reporting directly to the full Board, or (iv) the breach in any material respect by the Company of any of its other obligations or agreements set forth in this Agreement so long as, in each case: (x) you provided the Company with a written notice detailing the specific circumstances alleged to constitute Good Reason within 90 days after the first occurrence of such circumstances, (y) the Company failed to cure such Good Reason event(s) within 30 days following receipt of such notice to cure such circumstances in all material respects, and (z) following the Company’s failure to cure during the 30 day cure period, you terminate your position as Executive Chair (regardless of whether or not you remain on the Board) no later than 60 days after the expiration of such cure period.

As used herein, the term “Cause” means: (i) your commission of an act of fraud, embezzlement or similar dishonest act against any member of the Company or any customer, client or business associate of any member of the Company; (ii) Your conviction for any felony or crime of dishonesty (as determined by a court of competent jurisdiction, and which is not subject to further appeal); (iii) Any egregious or unwarranted conduct by you that materially discredits any member of the Company or is materially detrimental to the reputation or standing of any member of the Company; or (iv) Willful misconduct that is demonstrably deliberate on your part, or gross negligence.

As used herein, “Change in Control” shall have the meaning set forth in the Company’s 2021 Equity Incentive Plan.

/s/ Brittani Cushman	3/29/2024
Brittani Cushman, General Counsel	Date

I agree to the terms and conditions of the offer set forth above.

/s/ David Glazek	3/29/2024
David Glazek	Date

Exhibit A

Release of Claims

Schedule A

You will be responsible for carrying out all duties and responsibilities associated with your position as Executive Chairman of the Company and will be expected to devote the majority of your working time and attention to the Company.

Exhibit 31.1

CERTIFICATIONS

I, Graham Purdy, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Turning Point Brands, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 2, 2024	By:	/s/ Graham Purdy
		Graham Purdy
		President and Chief Executive Officer
		(Principal Executive Officer)

Exhibit 31.2

CERTIFICATIONS

I, Andrew Flynn, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Turning Point Brands, Inc.;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 2, 2024	By:	/s/ Andrew Flynn
		Andrew Flynn
		Chief Financial Officer
		(Principal Financial Officer)

Exhibit 31.3

CERTIFICATIONS

I, Brian Wigginton, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Turning Point Brands, Inc.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 2, 2024	By:	/s/ Brian Wigginton
		Brian Wigginton
		Chief Accounting Officer

Exhibit 32.1

CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Turning Point Brands, Inc. (the “Company”) for the quarterly period ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, Graham Purdy, President and Chief Executive Officer, Andrew Flynn, Chief Financial Officer, and Brian Wigginton, Chief Accounting Officer, of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.
---	---
Date: May 2, 2024	By:	/s/ Graham Purdy
---	---	---
		Graham Purdy
		President and Chief Executive Officer
		(Principal Executive Officer)
Date: May 2, 2024	By:	/s/ Andrew Flynn
---	---	---
		Andrew Flynn
		Chief Financial Officer
		(Principal Financial Officer)
Date: May 2, 2024	By:	/s/ Brian Wigginton
---	---	---
		Brian Wigginton
		Chief Accounting Officer

UNITED STATES

Table of Contents

Table of Contents

Table of Contents

Item 1.

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

217

Table of Contents

Table of Contents

Master Settlement Agreement (MSA)

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Convertible Senior Notes

Table of Contents

Table of Contents

Table of Contents

31, 2024

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Turning Point Brands, Inc. is a leading manufacturer, marketer and distributor of branded consumer products. We sell a wide range of products to adult consumers consisting of staple products with

Table of Contents

Table of Contents

Net Sales: For the three months ended March 31, 2024, consolidated net sales decreased to $97.1 million from $101.0 million for the three months ended March

For the three months ended March 31, 2024, net sales in the Stoker’s Products segment increased to $36.4 million from $33.7 million for the three months ended March 31, 2023, an increase of $2.7

Gross Profit: For the three months ended March 31, 2024, consolidated gross profit increased to $51.9 million from $48.6 million for the three months ended

Table of Contents

Selling, General, and Administrative Expenses: For the three months ended March 31, 2024, selling, general, and administrative expenses increased to $32.6

Interest Expense, net: For the three months ended March 31, 2024, interest expense, net decreased to $3.5 million from $4.0 million for the three months

Investment (Gain) Loss: For the three months ended March 31, 2024, we had an investment gain of $0.1 million compared to a $4.8 million loss for the three

Gain on Extinguishment of Debt: There was no gain or loss on extinguishment of debt for the three months ended March 31, 2024 compared to a $0.8 million gain

Income Tax Expense: Our income tax expense of $3.7 million was 23.4% of income before income taxes for the three months ended March 31, 2024. Our effective

Net Income (Loss) Attributable to Non-Controlling Interest: Net gain attributable to non-controlling interest was $0.2 million for the three months ended

Net Income Attributable to Turning Point Brands, Inc.: Due to the factors described above, net income attributable to Turning Point Brands, Inc. for the

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents